{"study_id": 110086, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the relationship between arachidonic acid (AA) and neuropsychological functioning and symptoms in recent-onset psychosis patients.", "results_summary": "Higher baseline AA levels correlated significantly with increased hostility/uncooperativeness in psychosis patients, but no longitudinal effects were reported. The study did not find significant positive effects of AA on neuropsychological functioning.", "population_specificity": "46 recent-onset psychosis patients (subset of a larger 50-patient trial).", "effective_dosage": "Not specified for AA (only EPA and DHA dosages provided).", "study_duration": "16 weeks (for the larger trial, but AA analysis focused on baseline data).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:27.656385+00:00"}
{"study_id": 110087, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether early supplementation of ARA and DHA improves brain maturation and neonatal outcomes in infants born before 29 weeks of gestation.", "results_summary": "The study suggests that ARA and DHA supplementation has the potential to improve brain maturation and reduce inflammation-related diseases in preterm infants, though specific results are pending completion of the trial.", "population_specificity": "Infants born before 29 weeks of gestation at Oslo University Hospital.", "effective_dosage": "100 mg/kg of ARA and 50 mg/kg of DHA daily.", "study_duration": "From the second day of life to 36 weeks' postmenstrual age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:31.109854+00:00"}
{"study_id": 110090, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the role of arachidonic acid-derived specialized pro-resolving mediators (SPMs) in resolving chronic lung inflammation in asthmatic patients.", "results_summary": "The study highlighted that arachidonic acid is metabolized by cyclooxygenases (COX) and lipoxygenases (LOX) to produce mediators like prostaglandins and lipoxins, which play a role in inflammation resolution in asthma. However, the abstract does not provide specific efficacy outcomes or statistical results.", "population_specificity": "Asthmatic patients with chronic lung inflammation.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:32.805799+00:00"}
{"study_id": 110088, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the predictive value and justify the routine preoperative use of multiple electrode aggregometry, including the arachidonic acid (ASPI) test, in assessing bleeding risk and transfusion requirements in CABG patients.", "results_summary": "The ASPI test significantly predicted total bleeding >1000 ml (AUC 0.695, p=0.039) with sensitivity and specificity of 70.8% and 41.8% at a cut-off \u2264453. However, the manufacturer's recommended ASPI cut-off (<600) showed no significant prediction for higher transfusion rates.", "population_specificity": "416 consecutive patients undergoing elective isolated coronary artery bypass grafting (CABG).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:33.225855+00:00"}
{"study_id": 110089, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the combined effects of Panax notoginseng saponins (PNS) and aspirin (ASA) on platelet activation and gastric injury, focusing on the arachidonic acid (AA) metabolism pathway.", "results_summary": "PNS + ASA further inhibited platelet activation markers (CD62p, GPIIb-IIIa) and aggregation compared to ASA alone, increased platelet inhibition rate, and suppressed COX-1 activity, reducing TXB production. The combination showed enhanced antiplatelet effects via AA metabolism modulation.", "population_specificity": "42 patients with stable coronary heart disease (SCHD) and chronic gastritis.", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:33.498640+00:00"}
{"study_id": 110092, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of EPA supplementation on plasma concentrations of EPA metabolites and SPMs, including changes in arachidonic acid (AA) levels, in MDD patients.", "results_summary": "The study found a significant reduction in plasma AA levels across all EPA supplementation arms, alongside an increase in AA-derived SPM lipoxin B4 (LXB4) at the 4 g/d dose.", "population_specificity": "61 MDD patients with a body mass index >25 kg/m\u00b2.", "effective_dosage": "1 g/d, 2 g/d, and 4 g/d of EPA.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:35.861819+00:00"}
{"study_id": 110091, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of arachidonic acid (AA) and linoleic acid (LA) derivatives in reproductive and pregnancy-related pathologies, including infertility, PCOS, preeclampsia, and gestational diabetes.", "results_summary": "The study found that AA and LA derivatives are linked to inflammation-related reproductive and pregnancy complications, such as PCOS, preeclampsia, and gestational diabetes, with specific metabolites (e.g., HETE, HODE) serving as potential biomarkers. Abnormal levels of these metabolites were associated with ovulation failure, infertility, and pregnancy pathologies, while controlled inflammation is crucial for fetal tolerance.", "population_specificity": "Women with reproductive and pregnancy-related conditions (e.g., PCOS, preeclampsia, gestational diabetes) and infertile men.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:35.931655+00:00"}
{"study_id": 110093, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the role of COX-2, an enzyme that processes arachidonic acid, in head and neck cancer progression and its potential as a therapeutic target.", "results_summary": "The study found that COX-2, which converts arachidonic acid to prostaglandins, promotes tumorigenesis in head and neck cancers by enhancing cell proliferation, inhibiting apoptosis, and stimulating angiogenesis. COX-2 inhibitors showed potential in restricting tumor cell growth and inducing apoptosis, suggesting therapeutic benefits.", "population_specificity": "Head and neck cancer patients, from premalignant lesions to invasive carcinomas.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:35.973547+00:00"}
{"study_id": 110095, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to elucidate the role of arachidonic acid (AA) and its metabolites in neuroinflammation, particularly in Alzheimer's disease (AD) and Parkinson's disease (PD).", "results_summary": "The study found that AA is metabolized into pro-inflammatory eicosanoids, which exacerbate neuroinflammation in AD and PD, but also produces lipoxins with anti-inflammatory effects. DHA and its metabolites counteract AA's pro-inflammatory effects by inhibiting eicosanoid production and regulating immune responses.", "population_specificity": "Patients with Alzheimer's disease and Parkinson's disease, as well as relevant animal models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:39.896717+00:00"}
{"study_id": 110096, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the molecular mechanisms of lenabasum, a CB2 agonist, involving arachidonic acid release and its subsequent pathways in inflammation resolution.", "results_summary": "The study proposed two divergent pathways for lenabasum's action, both involving arachidonic acid release, leading to cyclooxygenase 2-mediated and lipoxygenase-mediated routes, potentially increasing anti-inflammatory prostaglandins.", "population_specificity": "Not specified (abstract mentions therapeutic targets like scleroderma, cystic fibrosis, dermatomyositis, and lupus).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:40.964177+00:00"}
{"study_id": 110097, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether testosterone levels change in response to a DHA-enriched fish oil intervention and its relationship with omega-6 PUFA, arachidonic acid.", "results_summary": "The study found that changes in testosterone levels in males were inversely correlated with omega-6 PUFA, arachidonic acid, and dihomo-gamma-linolenic acid content in erythrocyte membranes. No treatment effect was observed in females.", "population_specificity": "Overweight and obese men and women without diabetes.", "effective_dosage": "860 mg DHA + 120 mg EPA/day (fish oil group); isocaloric control (corn oil).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:42.188235+00:00"}
{"study_id": 110099, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the storage properties and platelet aggregation response to arachidonic acid in platelet concentrates from hereditary hemochromatosis (HH) patients versus healthy donors.", "results_summary": "The study found no significant differences in platelet aggregation response to arachidonic acid or other quality markers between HH patients and healthy donors over 7-day storage. Platelet function and activation markers remained comparable in both groups.", "population_specificity": "Newly diagnosed hereditary hemochromatosis patients with elevated serum ferritin and healthy individuals.", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:43.386005+00:00"}
{"study_id": 110100, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare platelet reactivity between African-American and European-American subjects in response to arachidonic acid (AA) and other agonists, both at baseline and under treatment with aspirin or ticagrelor.", "results_summary": "African-Americans exhibited lower baseline platelet reactivity in response to AA and other agonists compared to European-Americans. The treatment effect of aspirin was greater in European-Americans with AA agonist, while ticagrelor's effect varied by race and agonist type.", "population_specificity": "African-American (n=209; 67% female; age 48\u00b112) and European-American (n=282; 50% female; age 50\u00b116) subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:44.462894+00:00"}
{"study_id": 110101, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of fish-oil supplementation in lactating mothers on the concentrations of n-3 LCPs, including arachidonic acid (AA), in human milk and its impact on child capillary blood.", "results_summary": "Fish-oil supplementation significantly increased DHA and EPA concentrations in human milk and decreased the AA/(DHA+EPA) ratio by 53.5%. However, HM DHA concentrations remained below international norms post-supplementation.", "population_specificity": "Lactating mothers (n=360) with children aged 6-12 months in a rural Ethiopian setting.", "effective_dosage": "215 mg DHA + 285 mg EPA per day (fish-oil capsules).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:44.985092+00:00"}
{"study_id": 110102, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of clopidogrel single antiplatelet therapy (SAPT) versus clopidogrel-based dual antiplatelet therapy (DAPT) on hemostatic system activation, including the role of arachidonic acid (AA) in platelet aggregation.", "results_summary": "The study used MEA-AA triggered aggregometry to assess platelet function but did not report specific outcomes related to AA's effects. The abstract focuses on comparing SAPT and DAPT rather than isolating AA's impact.", "population_specificity": "44 volunteers", "effective_dosage": "Not specified for AA (aspirin dosage: 100 mg)", "study_duration": "6 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:48.878715+00:00"}
{"study_id": 110084, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to investigate the association of platelet-related microRNAs with monocyte-platelet aggregate formation in ACS patients on dual antiplatelet therapy and compare outcomes between prasugrel- and ticagrelor-treated patients.", "results_summary": "The study found that platelet-related miR-21 and miR-126 are associated with monocyte-platelet aggregate formation in ACS patients on dual antiplatelet therapy, with similar levels observed between prasugrel- and ticagrelor-treated patients.", "population_specificity": "160 consecutive ACS patients on dual antiplatelet therapy with low-dose aspirin and either prasugrel or ticagrelor.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:49.189322+00:00"}
{"study_id": 110103, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of duodenal-jejunal bypass liners (DJBLs) on blood concentrations of essential fatty acids (EFAs) and bioactive polyunsaturated fatty acids (PUFAs), including arachidonic acid.", "results_summary": "The study found that DJBL therapy led to significantly lower absolute concentrations of arachidonic acid compared to controls at 6 and 11.5 months follow-up, alongside reductions in total serum cholesterol and LDL-cholesterol.", "population_specificity": "Patients aged 18-65 years with type-2 diabetes mellitus and body mass index 30-50 kg/m\u00b2.", "effective_dosage": "Not specified", "study_duration": "11.5 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:49.380359+00:00"}
{"study_id": 110108, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not mention Arachidonic Acid or its study goals.", "results_summary": "The abstract does not discuss Arachidonic Acid or its effects.", "population_specificity": "Not specified (abstract focuses on Chloroquine and Hydroxychloroquine).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:51.450891+00:00"}
{"study_id": 110105, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the biological effects of isolevuglandins (isoLGs) derived from arachidonic acid oxidation and their role in various diseases.", "results_summary": "The study found that isoLGs, formed from arachidonic acid oxidation, covalently modify proteins and lipids, contributing to oxidative stress, inflammation, and various pathologies, including cardiovascular diseases, neurodegeneration, and aging.", "population_specificity": "Not specified (review of existing data).", "effective_dosage": "Not available.", "study_duration": "Not applicable (review study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:51.453390+00:00"}
{"study_id": 110104, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the mechanisms of aspirin's antithrombotic effects, including the role of arachidonic acid-induced platelet reactivity.", "results_summary": "The study found a dose-dependent relationship between aspirin and reduced high platelet reactivity (measured via arachidonic acid-induced aggregometry), enhanced antithrombin activity, and suppressed monocytes. Aspirin's antithrombotic effects involved red blood cells, monocytes, and platelets.", "population_specificity": "530 subjects (including 40 without aspirin use, 24 taking 25-50 mg/d aspirin, and 466 taking 75-100 mg/d aspirin) with ischemic atherothrombotic diseases.", "effective_dosage": "25-50 mg/d and 75-100 mg/d aspirin.", "study_duration": "1 month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:51.575719+00:00"}
{"study_id": 110107, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the relationship between chronic kidney disease (CKD) duration and the synthesis of inflammatory mediators derived from arachidonic acid, focusing on oxidative stress and eicosanoid profiles.", "results_summary": "The study found that CKD patients had significantly higher concentrations of several inflammatory mediators (13(S)-HODE, 5(S)-HETE, 12(S)-HETE, 15(S)-HETE, 5(S)-oxoETE, 16(RS)-HETE, and 5(S),6(R),15(R)-lipoxinA4) but lower levels of 9(S)-HODE compared to healthy controls. Lipoxin levels decreased drastically over the course of CKD, suggesting potential for synthetic LXA4 analogues as antioxidant therapy.", "population_specificity": "121 patients with chronic kidney disease and 87 healthy volunteers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:54.563708+00:00"}
{"study_id": 110110, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if women at risk of gestational diabetes mellitus (GDM) exhibit a unique fatty acid profile, including elevated levels of arachidonic acid (ArA), compared to healthy controls.", "results_summary": "The study found that GDM women had elevated levels of n-6 fatty acids, including arachidonic acid (ArA), and depressed levels of n-3 fatty acids, indicating an abnormal pattern of sequential n-6 metabolism. These findings suggest a potential link between ArA levels and GDM risk.", "population_specificity": "Pregnant women at risk of gestational diabetes mellitus (GDM) and normal healthy controls (NHC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:57.509319+00:00"}
{"study_id": 110109, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate how \u03c9-3 PUFA supplementation affects eicosanoid metabolites derived from arachidonic acid and its impact on lipid metabolism and endothelial function in AMI patients.", "results_summary": "The study found that \u03c9-3 PUFA therapy significantly reduced levels of prostaglandin J2 (PGJ2) and leukotriene B4, both derived from arachidonic acid, and improved lipid metabolism and endothelial function. These changes were correlated with alterations in eicosanoid metabolic status.", "population_specificity": "Participants with acute myocardial infarction (AMI) after successful percutaneous coronary intervention.", "effective_dosage": "2 g daily \u03c9-3 PUFA.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:57.787488+00:00"}
{"study_id": 110112, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate whether arachidonic acid (AA) and other bioactive lipids could inactivate SARS-CoV-2 and potentially benefit in the prevention and treatment of COVID-19.", "results_summary": "The study suggests that AA and other bioactive lipids may inactivate SARS-CoV-2, modulate immune responses, and reduce inflammation, potentially benefiting COVID-19 management. It also notes that low AA levels in certain populations may increase susceptibility to severe COVID-19 outcomes.", "population_specificity": "Subjects with insulin resistance, obesity, type 2 diabetes, hypertension, coronary heart disease, and the elderly were highlighted as having low AA levels.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Statins, colchicine, and corticosteroids were mentioned as influencing bioactive lipid metabolism.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:58.695428+00:00"}
{"study_id": 110115, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the potential of antimalarials, which are non-selective inhibitors of phospholipase A, to act against SARS-CoV-2 in both peripheral organs and the central nervous system.", "results_summary": "The abstract does not provide specific findings about Arachidonic Acid's effects, focusing instead on the properties of antimalarials and their potential role in combating COVID-19.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:59.464815+00:00"}
{"study_id": 110113, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the structural and kinetic implications of lipoxygenases (LOX) on catalysis selectivity and the basic and clinical implications of their inhibition and interactions with nitric oxide, focusing on arachidonic acid (AA) as a substrate.", "results_summary": "The abstract highlights that mammalian LOXs use arachidonic acid to synthesize leukotrienes and other oxidized-lipid intermediaries involved in the inflammatory response, but does not provide specific results on AA's effects.", "population_specificity": "Not specified (review of mammalian LOXs in general).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:00.037888+00:00"}
{"study_id": 110114, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of arachidonic acid (AA) in sickle cell disease (SCD) inflammation and assess the therapeutic potential of omega-3 fatty acids (DHA and EPA) to counteract AA's pro-inflammatory effects.", "results_summary": "The study found that SCD patients have an abnormal fatty acid composition in blood cell membranes, characterized by a high pro-inflammatory AA to anti-inflammatory DHA/EPA ratio. Omega-3 fatty acids (DHA and EPA) improved rheological properties, inflammation, and hemolysis in SCD, suggesting their potential as a therapeutic intervention.", "population_specificity": "Patients with sickle cell disease (SCD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:00.294289+00:00"}
{"study_id": 110116, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combined DHA and AA supplementation during toddlerhood improved socioemotional outcomes in preterm children, including reducing ASD risk.", "results_summary": "The study found no broad socioemotional benefits from DHA + AA supplementation but observed a decreased risk of clinical concern for ASD in preterm children. Further research in larger samples and longer follow-up was recommended.", "population_specificity": "Preterm children (toddlers)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:01.937681+00:00"}
{"study_id": 110098, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-inflammatory potential of an arachidonic acid derivative (AM404) in human microglia and SCA3 models.", "results_summary": "The study assessed AM404 among other compounds for anti-inflammatory effects, but specific results for the arachidonic acid derivative were not detailed in the abstract.", "population_specificity": "Human HMC3 microglia and SCA3 ATXN3/Q models.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:04.537653+00:00"}
{"study_id": 110117, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate possible changes in the arachidonic acid (AA) pathway in bipolar disorder (BD) through a systematic review of observational studies.", "results_summary": "The studies showed contradictory results regarding AA and phospholipase A2 (PLA2), and no primary articles assessing cyclooxygenase (COX) or prostaglandins E2 (PGE2) were included. The review concluded that the inflammatory pathway of AA requires further investigation.", "population_specificity": "246 BD patients, 20 depression patients, and 425 healthy controls.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:05.715898+00:00"}
{"study_id": 110118, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of arachidonic acid (AA) derivatives in neuroinflammatory processes and their potential therapeutic implications for depression.", "results_summary": "The study found that AA metabolites have both pro-inflammatory and anti-inflammatory properties, with an imbalance potentially contributing to chronic neuroinflammation linked to depression. It highlighted the complexity of targeting AA-derived pathways for therapeutic benefits.", "population_specificity": "Not specified (focus on neuroinflammatory processes in the brain, likely relevant to individuals with depression).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:06.544890+00:00"}
{"study_id": 110122, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers were attempting to determine the link between arachidonic acid deficiency and severe cystic fibrosis phenotypes.", "results_summary": "The study suggests that severe cystic fibrosis phenotypes are associated with a deficiency of linoleic acid, the precursor of arachidonic acid, and highlights the role of arachidonic acid release via phospholipase A.", "population_specificity": "Individuals with cystic fibrosis (CF).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:07.631347+00:00"}
{"study_id": 110119, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the potential association between the arachidonic acid (AA) pathway and multiple sclerosis (MS) by reviewing animal and human studies.", "results_summary": "The study found that eicosanoids play significant roles in MS and Experimental Autoimmune Encephalomyelitis (EAE), with COX and LOX inhibitors showing beneficial effects. Hybrid compounds targeting the AA pathway were suggested as a potential innovative treatment approach for MS.", "population_specificity": "Animal models (EAE) and human clinical trial participants with MS.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:07.636991+00:00"}
{"study_id": 110120, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to compare dietary intake and status of polyunsaturated fatty acids (PUFA), including Arachidonic Acid, in metabolically healthy vs. unhealthy and obese vs. nonobese individuals.", "results_summary": "The abstract does not specify results related to Arachidonic Acid's effects, only noting higher energy intake in metabolically unhealthy obese and nonobese individuals.", "population_specificity": "171 participants categorized by metabolic health (healthy/unhealthy) and obesity status (obese/nonobese).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:08.236221+00:00"}
{"study_id": 110121, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to describe the pathways, receptors, physiological roles, disease associations, and inhibitors related to eicosanoid synthesis, with a focus on arachidonic acid as the primary substrate.", "results_summary": "The study found that arachidonic acid-derived eicosanoids have diverse physiological roles in inflammation, immunity, and systems like vascular, renal, gastrointestinal, and female reproductive, but are also implicated in diseases such as inflammatory conditions and cancer.", "population_specificity": "Not specified (general physiological and disease contexts).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:08.658155+00:00"}
{"study_id": 110123, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether combining exercise with LCPUFA (including arachidonic acid) improves cognitive function in non-demented elderly individuals, particularly those with low skeletal muscle mass.", "results_summary": "The study found no significant overall cognitive improvements from exercise with LCPUFA supplementation. However, in participants with low skeletal muscle mass, the combination improved selective attention and working memory compared to the control group.", "population_specificity": "Non-demented elderly Japanese individuals, with a subgroup analysis focusing on those with low skeletal muscle mass.", "effective_dosage": "120 mg/day of arachidonic acid (combined with 300 mg/day docosahexaenoic acid and 100 mg/day eicosapentaenoic acid).", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:11.088317+00:00"}
{"study_id": 110124, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the role of arachidonic acid metabolic disturbance in nonalcoholic fatty liver disease (NAFLD) and its potential implications for treatment.", "results_summary": "The study found that arachidonic acid metabolic disturbance, along with fatty acid accumulation and ceramide overload, contributes to NAFLD. These findings may inform novel therapeutic approaches for NAFLD.", "population_specificity": "Individuals with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:11.583713+00:00"}
{"study_id": 110125, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to summarize dysregulated PUFA metabolism, particularly arachidonic acid, in allergic diseases and discuss potential therapeutic strategies to correct this imbalance.", "results_summary": "The study found that dysregulated metabolism of arachidonic acid leads to overproduction of cysteinyl leukotrienes and impaired synthesis of pro-resolving mediators, contributing to conditions like severe asthma and eosinophilic chronic rhinosinusitis. Multi-omics analysis revealed metabolic derangement in eosinophils from inflamed tissues of ECRS patients.", "population_specificity": "Patients with eosinophilic chronic rhinosinusitis (ECRS), severe asthma, and aspirin-exacerbated respiratory disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:14.322785+00:00"}
{"study_id": 110128, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify metabolic pathways, including arachidonic acid metabolism, affected by aspirin treatment and their potential role in colorectal cancer chemoprevention.", "results_summary": "The study found that arachidonic acid metabolism was associated with 325 mg/day aspirin treatment, suggesting a potential role in aspirin's chemopreventive effects. Glycerophospholipid metabolism, which provides precursors for arachidonic acid-derived eicosanoids, was also linked to aspirin's effects.", "population_specificity": "325 participants from the Aspirin/Folate Polyp Prevention Study, undergoing colonoscopy.", "effective_dosage": "81 mg/day or 325 mg/day aspirin.", "study_duration": "Approximately 3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:15.104730+00:00"}
{"study_id": 110132, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential association between the arachidonic acid (AA) pathway and COVID-19 pathophysiology.", "results_summary": "The study found that COX-2 and prostaglandins (PGs), particularly PGE, are implicated in COVID-19 pathophysiology, suggesting a role for the AA pathway in the disease.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:15.282133+00:00"}
{"study_id": 110130, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether adding EPA to statin therapy could alter LDL and HDL particle heterogeneity and influence the EPA/AA ratio in stable CAD patients.", "results_summary": "EPA supplementation significantly reduced medium, small, and very small LDL particles while increasing large and very large HDL particles. The EPA/AA ratio correlated with these changes, suggesting a potential anti-atherosclerotic effect.", "population_specificity": "Stable coronary artery disease (CAD) patients already receiving statin therapy (n=60).", "effective_dosage": "1800 mg/day of EPA.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:15.520748+00:00"}
{"study_id": 110129, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential role of arachidonic acid-derived epoxyeicosatrienoic acids and soluble epoxide hydrolase inhibitors in mitigating COVID-19-related hyperinflammation and organ failure.", "results_summary": "The study suggests that arachidonic acid-derived epoxyeicosatrienoic acids may alleviate systemic hyperinflammatory responses in COVID-19 by modulating endoplasmic reticulum stress and inflammation resolution. Soluble epoxide hydrolase inhibitors showed anti-inflammatory effects in preclinical models, potentially offering a therapeutic approach for COVID-19.", "population_specificity": "Preclinical disease models and theoretical application to COVID-19 patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:16.381410+00:00"}
{"study_id": 110131, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize the progress of research on the three major metabolic pathways of arachidonic acid (COX, LOX, CYP) in relation to myocardial ischemia-reperfusion injury (MIRI).", "results_summary": "The study highlights that arachidonic acid's metabolic pathways are closely linked to cardiovascular disease development, with its metabolites playing roles in ischemia-reperfusion injury. The paper reviews the involvement of COX, LOX, and CYP pathways in MIRI but does not present new experimental data.", "population_specificity": "Patients with myocardial ischemic diseases or those undergoing heart treatments (e.g., open heart surgery, coronary artery bypass grafting).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:17.710727+00:00"}
{"study_id": 110133, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of lipid-lowering therapy (pitavastatin monotherapy vs. pitavastatin + ezetimibe) on the eicosapentaenoic acid/arachidonic acid ratio in patients with acute coronary syndrome (ACS).", "results_summary": "Pitavastatin monotherapy significantly improved the eicosapentaenoic acid/arachidonic acid ratio in ACS patients, while the combination therapy (pitavastatin + ezetimibe) did not improve the ratio despite significantly lowering LDL-C. The inhibition of ratio improvement with ezetimibe may impact cardiovascular disease prognosis.", "population_specificity": "Patients with acute coronary syndrome (ACS) and dyslipidemia.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:20.778122+00:00"}
{"study_id": 110135, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the long-term clinical outcomes of different P2Y12 inhibitors (including clopidogrel, ticagrelor, and prasugrel) in ACS patients, with a focus on platelet aggregation measured via ADP- and arachidonic acid (AA)-induced responses.", "results_summary": "The study found that AA-induced platelet aggregation was less effectively inhibited by clopidogrel in diabetic patients compared to non-diabetic patients. Additionally, clopidogrel's efficacy decreased with ACS severity, showing higher platelet aggregation in STEMI and non-STEMI patients versus unstable angina.", "population_specificity": "708 patients with acute coronary syndrome (ACS), including those with STEMI, non-STEMI, and unstable angina.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 5.6 years (IQR 4.9-6.5 years) for mortality; 1 year for MACE.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:22.330339+00:00"}
{"study_id": 110138, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if allometric scaling models could improve translational validity for polyunsaturated fats, including Arachidonic Acid, between rodent models and humans.", "results_summary": "The study found that basing lipid composition on percent of energy may yield comparable outcomes between mice and humans, suggesting potential for effective extrapolation of non-energy producing nutrients like Arachidonic Acid.", "population_specificity": "Mice and human clinical trial data (specific human population not detailed).", "effective_dosage": "Increasing levels of n-6 polyunsaturated fatty acids (human equivalent doses, exact amounts not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:23.341276+00:00"}
{"study_id": 110136, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether celecoxib and aspirin, which reduce brain arachidonic acid (AA) metabolism, enhance the efficacy of mood stabilizers in bipolar disorder patients.", "results_summary": "Celecoxib significantly improved mood stabilizer efficacy in manic and treatment-resistant bipolar depression patients, while chronic low-dose aspirin was associated with symptom reduction and fewer manic episodes in population studies.", "population_specificity": "Bipolar disorder patients (manic inpatients and treatment-resistant depression patients) and general populations on mood stabilizers.", "effective_dosage": "Celecoxib (dosage not specified), aspirin (30-80 mg/day and 75-150 mg/day).", "study_duration": "6-8 weeks for RCTs; chronic use in population studies.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:23.391223+00:00"}
{"study_id": 110140, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to summarize the effects of progestogens, including their influence on arachidonic acid release, in the context of assisted reproduction and miscarriage treatment.", "results_summary": "The abstract mentions that progestogens affect arachidonic acid release, but no specific findings about its efficacy or safety are detailed. The focus is on progestogens' broader reproductive roles rather than isolated arachidonic acid effects.", "population_specificity": "Women undergoing assisted reproductive technologies (ART) or those with threatened/recurrent miscarriage.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:24.477508+00:00"}
{"study_id": 110137, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the role of lipoxin (an arachidonic acid metabolite) in treating infertility and maintaining normal pregnancy.", "results_summary": "Lipoxin A4 (LXA4) is crucial for menstrual cycles, embryo implantation, pregnancy, and delivery, but high levels peri-implantation may cause early pregnancy loss, while insufficient levels later can impair fetal growth. LXA4 levels fluctuate during pregnancy, peaking in the luteal phase and final stages to aid placental separation.", "population_specificity": "Animal and cell models (no human studies mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Salicylic acid can trigger lipoxin synthesis by acetylating cyclooxygenase-2.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:24.601416+00:00"}
{"study_id": 110139, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers evaluated whether elective carotid artery stenting (CAS) with urgent best medical therapy, including omega-3 fatty acid ethyl esters, reduces recurrent stroke in patients with symptomatic severe carotid artery stenosis.", "results_summary": "The study found that serum EPA/AA ratios were significantly lower in the acute ischemic minor stroke group at baseline but increased significantly after treatment. No recurrent ischemic stroke occurred under urgent best medical treatment before elective CAS.", "population_specificity": "Patients with severe carotid artery stenosis, divided into acute ischemic minor stroke (59 patients) and asymptomatic (72 patients) groups.", "effective_dosage": "Not specified for arachidonic acid; omega-3 fatty acid ethyl esters were administered as part of dual antiplatelet therapy and statin therapy.", "study_duration": "4 weeks before CAS and 3 months after CAS.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:24.666506+00:00"}
{"study_id": 110141, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether adding bovine milk fat globule membrane (bMFGM) to infant formula, which includes arachidonic acid (ARA), affects physical growth and cognitive development compared to standard formula or human milk.", "results_summary": "The abstract does not report specific results regarding ARA's effects, as the study is ongoing or results are pending. The primary outcomes will assess growth and cognitive development at 730 days of age.", "population_specificity": "Infants exclusively receiving breast milk (n=200) or infant formula (n=340) initiated before 4 months of age.", "effective_dosage": "25 mg ARA per 100 kcal in the standard formula.", "study_duration": "Until 12 months of age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:26.639899+00:00"}
{"study_id": 110143, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the causal association between arachidonic acid levels and colorectal cancer (CRC) risk by integrating evidence from observational studies and Mendelian randomization (MR) analyses.", "results_summary": "The study found that decreased arachidonic acid levels were likely causally associated with lower CRC risk, suggesting a protective effect. This conclusion was supported by triangulating evidence from both observational and MR studies.", "population_specificity": "Individuals assessed for colorectal cancer risk (specific demographics not detailed in the abstract).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:29.962483+00:00"}
{"study_id": 110142, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare metabolomic profiles, including arachidonic acid metabolism, between bicuspid and tricuspid aortic valve patients undergoing TAVR to identify differences in hemodynamics and post-procedural remodeling.", "results_summary": "Elevated arachidonic acid metabolism in BAV patients was associated with more severe baseline hemodynamics and worse left ventricular reserve remodeling after TAVR, suggesting a potential metabolic marker for disease severity.", "population_specificity": "57 patients (33 with bicuspid aortic valve, 24 with tricuspid aortic valve) undergoing transcatheter aortic valve replacement.", "effective_dosage": "Not specified", "study_duration": "Blood samples taken before TAVR and 7 days post-TAVR.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:30.101337+00:00"}
{"study_id": 110145, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the biomarker patterns of platelet activation induced by arachidonic acid (a biochemical agonist) versus shear-mediated platelet activation.", "results_summary": "Arachidonic acid was found to be a potent inducer of integrin \u03b1IIb\u03b23 activation and P-selectin exposure, but unlike shear stress, it did not significantly increase phosphatidylserine externalization (PSE) or procoagulant activity.", "population_specificity": "Gel-filtered human platelets (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:31.588571+00:00"}
{"study_id": 110144, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize current knowledge on the biochemistry of polyunsaturated fatty acids (PUFAs), particularly arachidonic acid (AA) and docosahexaenoic acid (DHA), in cystic fibrosis (CF) and explore the potential of fenretinide to correct their pro-inflammatory imbalance.", "results_summary": "The study found that CF is associated with increased levels of arachidonic acid and decreased levels of DHA, contributing to a pro-inflammatory state. Fenretinide was identified as a potential treatment to correct this imbalance.", "population_specificity": "Patients with cystic fibrosis (CF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:32.061421+00:00"}
{"study_id": 110146, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived prostanoids in normal physiology, disease, and the effects of NSAIDs on their biosynthesis.", "results_summary": "The study highlights that prostanoids derived from arachidonic acid have diverse functions in health and disease, with NSAIDs inhibiting their production via COX, but this inhibition carries cardiovascular risks. Targeting mPGES-1 downstream of COX may offer therapeutic benefits with reduced thrombotic risk compared to COX-2 inhibitors.", "population_specificity": "Not specified (general discussion of mechanisms and clinical implications)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "NSAIDs (COX inhibitors)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:33.148515+00:00"}
{"study_id": 110148, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to understand the role of aberrant arachidonic acid metabolism in the pathogenesis of aspirin-exacerbated respiratory disease (AERD).", "results_summary": "The study found that arachidonic acid metabolism in AERD leads to elevated leukotriene E4 and decreased prostaglandin E2, contributing to disease severity. It also highlighted the involvement of mast cell mediators and immune cells in AERD pathogenesis.", "population_specificity": "Patients with aspirin-exacerbated respiratory disease (AERD), characterized by chronic rhinosinusitis with nasal polyps, asthma, and NSAID sensitivity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:33.342023+00:00"}
{"study_id": 110147, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the effects of epoxyeicosatrienoic acids (EETs), synthesized from arachidonic acid, on cardiovascular function, the nervous system, the kidney, metabolic disease, and the lungs.", "results_summary": "The study found that EETs, derived from arachidonic acid, play a beneficial role in the lungs, including inducing vasorelaxation in the bronchi and stimulating calcium-related effects. The presence of CYPs and EETs in the lungs was documented, supporting their physiological relevance.", "population_specificity": "Not specified (general review of EET effects across tissues).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:33.764373+00:00"}
{"study_id": 110149, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Arachidonic Acid pathways in chronic inflammatory diseases and evaluate the potential of flavonoids to modulate these pathways.", "results_summary": "The study found that Arachidonic Acid pathways are involved in initiating inflammatory responses, and flavonoids can modulate these pathways by activating the Nrf2 pathway, potentially inhibiting chronic inflammatory diseases.", "population_specificity": "Not specified (in-vivo and in-vitro models mentioned, but no human population details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:35.122944+00:00"}
{"study_id": 110150, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers were investigating the formation of 5-oxo-ETE, an arachidonic acid metabolite, through the oxidation of 5S-HETE by NADP.", "results_summary": "The study identified 5-oxo-ETE as a metabolite of arachidonic acid, formed via oxidation of 5S-HETE by NADP. No specific effects or outcomes related to arachidonic acid's efficacy or safety were reported.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:38.154580+00:00"}
{"study_id": 110151, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the role of ALOX5/CysLTs in Alzheimer's disease pathophysiology and discuss the potential of their blockers as therapeutic options.", "results_summary": "The study found elevated levels of ALOX5/CysLTs in Alzheimer's disease models and demonstrated that genetic/pharmacological interventions targeting these molecules can alleviate disease-related behavioral and pathological conditions. Clinical relevance was also observed in AD brain samples.", "population_specificity": "Transgenic and sporadic models of Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:38.364485+00:00"}
{"study_id": 110152, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of aspirin on serum uric acid (SUA) levels and arachidonic acid-induced platelet aggregation in older Chinese individuals with cardiovascular risk factors.", "results_summary": "Aspirin (50 mg and 100 mg) significantly reduced arachidonic acid-induced platelet aggregation and decreased SUA levels in hyperuricaemic subjects, while SUA levels remained unchanged in normouricaemic subjects.", "population_specificity": "Chinese individuals over 60 years of age with coronary artery disease or multiple cardiovascular risk factors.", "effective_dosage": "50 mg or 100 mg aspirin daily.", "study_duration": "Two weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:40.428663+00:00"}
{"study_id": 110156, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to highlight the unique lipid composition of human milk, particularly its supply of long-chain polyunsaturated fatty acids like arachidonic acid (ARA).", "results_summary": "The abstract notes that human milk provides unique long-chain polyunsaturated fatty acids, including arachidonic acid, but does not report specific effects or outcomes related to ARA.", "population_specificity": "Infants (implied by focus on breastfeeding and human milk).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.293880+00:00"}
{"study_id": 110155, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how genetic variation in the FADS gene cluster affects the metabolism of omega-6 PUFAs, particularly ARA, from borage oil and soybean oil supplementation.", "results_summary": "BO supplementation increased serum concentrations of GLA and DGLA in a genotype-dependent manner, with DGLA rising more significantly in TT genotype individuals. ARA levels varied by genotype and increased modestly with BO, suggesting FADS variation influences the balance between DGLA and ARA.", "population_specificity": "64 healthy non-Hispanic white adults.", "effective_dosage": "Not specified (modest daily dose of BO containing 23% GLA).", "study_duration": "4 weeks per intervention with an 8-week washout period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.633169+00:00"}
{"study_id": 110157, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers sought to clarify the effect of APOE\u025b4/\u025b4 on the ratio of plasma DHA and EPA to AA and on hippocampal volumes after DHA supplementation.", "results_summary": "APOE\u025b4/\u025b4 carriers showed a lower increase in plasma DHA/AA and EPA/AA after DHA supplementation, reducing brain delivery and affecting efficacy. APOE\u025b2/\u025b3 carriers had greater increases in plasma EPA/AA and less hippocampal volume decline compared to \u025b4/\u025b4 carriers.", "population_specificity": "275 participants with mild probable Alzheimer's disease, including APOE\u025b4 carriers and non-carriers.", "effective_dosage": "Not specified", "study_duration": "18 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:43.027345+00:00"}
{"study_id": 110153, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether genetic variants and polyunsaturated fatty acids, particularly arachidonic acid, are associated with aortic stenosis and aortic valve calcium.", "results_summary": "The study found that higher arachidonic acid levels were associated with increased risk of aortic valve calcium and aortic stenosis, suggesting a potential link between \u03c9-6 fatty acid biosynthesis and these conditions. Mendelian randomization supported a causal relationship between arachidonic acid and aortic stenosis.", "population_specificity": "44,703 participants of self-reported European ancestry from the GERA cohort, with additional replication in other cohorts totaling 312,118 individuals.", "effective_dosage": "Not specified", "study_duration": "Data analyzed from 1996 to 2019, but intervention duration not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:43.491841+00:00"}
{"study_id": 110158, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether third-generation hydroxyethyl starch solutions cause kidney injury or haemostatic abnormalities in cardiac surgery patients compared to human albumin 5%.", "results_summary": "The study found that postoperative urinary neutrophil gelatinase-associated lipocalin concentrations (a marker of kidney injury) were slightly lower with hydroxyethyl starch compared to human albumin, suggesting non-inferiority in kidney function and haemostasis. Secondary outcomes, including coagulation measures and platelet function, were also evaluated.", "population_specificity": "Patients aged 40-85 undergoing elective aortic valve replacement, with or without coronary artery bypass grafting.", "effective_dosage": "6% hydroxyethyl starch 130/0.4 vs. 5% human albumin (plasma volume replacement).", "study_duration": "Intra-operative administration (specific duration not mentioned).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:46.195101+00:00"}
{"study_id": 110159, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers compared the effects of ticagrelor and prasugrel on platelet activation, including responses to arachidonic acid (AA), in acute coronary syndrome (ACS) patients.", "results_summary": "AA-induced platelet aggregation was similar in patients on ticagrelor and prasugrel, with no significant difference observed (p \u2265 0.3). The study did not find ticagrelor or prasugrel to differentially affect AA-mediated platelet responses.", "population_specificity": "160 ACS patients (80 on ticagrelor, 80 on prasugrel) post-percutaneous coronary intervention.", "effective_dosage": "Not specified", "study_duration": "Measurements taken on day 3 after intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:47.899970+00:00"}
{"study_id": 110161, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether remote ischemic preconditioning (RIPC) inhibits agonist-induced conformational activation of platelet \u03b1, specifically in response to arachidonic acid.", "results_summary": "The study found that RIPC inhibits conformational activation of platelet \u03b1 in response to arachidonic acid, suggesting a potential modulatory effect on platelet function. The results were derived from platelet aggregometry and flow cytometry analyses.", "population_specificity": "Patients with angiographically confirmed coronary artery disease (83% male, mean age 63.3 \u00b1 13.2 years, 95% on aspirin, 81% on P2Y inhibitors).", "effective_dosage": "Not specified", "study_duration": "Immediate effects measured before and after RIPC/sham treatment (duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:49.769226+00:00"}
{"study_id": 110160, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the antithrombotic effects of ticagrelor alone versus ticagrelor plus aspirin (ASA) in high-risk PCI patients, with secondary endpoints assessing platelet reactivity to arachidonic acid and other stimuli.", "results_summary": "The study found that ticagrelor monotherapy had similar antithrombotic potency to ticagrelor plus ASA in ex vivo assays, but markers sensitive to cyclo-oxygenase-1 blockade (affected by ASA) were increased without ASA. Platelet reactivity to arachidonic acid was measured but not directly compared for efficacy.", "population_specificity": "High-risk patients undergoing PCI with drug-eluting stents.", "effective_dosage": "Not specified for arachidonic acid (study focused on ticagrelor and ASA).", "study_duration": "Pharmacodynamic assessments were repeated 1 to 6 months post-randomization.", "interactions": "None mentioned for arachidonic acid (study focused on ticagrelor-ASA interaction).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:50.819359+00:00"}
{"study_id": 110165, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of snake venom phospholipases (svPLA) in the pathologies caused by snakebite, focusing on inflammation and other dysregulated physiological mechanisms.", "results_summary": "The abstract highlights that snake venom components, particularly svPLA, contribute to inflammation, coagulation, neurotransmission, and cell survival disruptions, but does not specifically address Arachidonic Acid's effects.", "population_specificity": "Not specified (review of snake venom mechanisms, not human subjects).", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:50.876649+00:00"}
{"study_id": 110162, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate how aspirin affects microRNA expression and arachidonic acid metabolism in cardiac and peri-myocardial fat-derived mesenchymal stem cells.", "results_summary": "The study found that aspirin treatment differentially altered microRNA expression and suppressed endogenous arachidonic acid metabolite generation in cardiac MSCs, while causing milder changes in peri-cardiac adipose tissue-derived MSCs.", "population_specificity": "Human myocardium and peri-myocardial fat tissue-derived mesenchymal stem cells (MSCs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:50.908722+00:00"}
{"study_id": 110163, "supplement_id": 885, "safety_score": "75", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to determine whether antiplatelet pretreatment (AP) before intravenous thrombolysis (IVT) affects platelet aggregation and clinical outcomes in acute ischemic stroke (AIS) patients, specifically focusing on arachidonic acid-induced platelet aggregation.", "results_summary": "The study found that prior AP significantly reduced arachidonic acid-induced maximum platelet aggregation (MPA) 3 hours after thrombolysis. AP did not increase the risk of symptomatic intracranial hemorrhage (sICH) or mortality but also showed no association with improved clinical outcomes.", "population_specificity": "AIS patients treated with IVT at the Neurology Department of Nanjing First Hospital (n=59, 23 of whom were on prior AP).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:52.471162+00:00"}
{"study_id": 110166, "supplement_id": 885, "safety_score": "85", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety of Iloprost, a prostacyclin analogue, by assessing changes in platelet aggregation (via arachidonic acid and other assays) in OHCA patients.", "results_summary": "The study found no significant difference in platelet aggregation between Iloprost and placebo groups using the ASPI (arachidonic acid), TRAP, RISTO, and ADP assays. No increased bleeding risk was observed, though a decline in platelet aggregation was noted for ASPI and ADP assays within 96 hours post-OHCA.", "population_specificity": "Out-of-hospital cardiac arrest (OHCA) patients (n=46).", "effective_dosage": "1 ng/kg/min (Iloprost infusion).", "study_duration": "48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:52.662204+00:00"}
{"study_id": 110167, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether low-dose metoprolol and aspirin, by reducing platelet response to arachidonic acid, could lower cardiovascular risk markers and anxiety in recently bereaved individuals.", "results_summary": "The study found that metoprolol and aspirin significantly reduced platelet response to arachidonic acid (P < .001) and lowered anxiety and cardiovascular risk markers without affecting bereavement intensity. No significant adverse safety impacts were observed.", "population_specificity": "Recently bereaved spouses (n = 73) or parents (n = 12) of deceased individuals, aged 66.1 \u00b1 9.4 years, from 5 hospitals in Sydney, Australia.", "effective_dosage": "Aspirin 100 mg daily, metoprolol 25 mg daily.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:57.228986+00:00"}
{"study_id": 110169, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether COX activity, involving arachidonic acid, contributes to bradykinin-induced dermal extravasation in mice and humans.", "results_summary": "COX inhibitors, including ibuprofen, significantly reduced bradykinin-induced dermal extravasation in mice and improved wheal resolution in humans, suggesting a role for arachidonic acid in this pathway.", "population_specificity": "Mice with eNOS deficiency, C57BL/6J mice, and 38 healthy human volunteers.", "effective_dosage": "Ibuprofen 600 mg (oral, single dose in humans).", "study_duration": "Not specified for mice; single-dose intervention in humans.", "interactions": "COX inhibitors (e.g., ibuprofen, diclofenac) showed interaction effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:59.362588+00:00"}
{"study_id": 110168, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze the inhibitory effect of aspirin (ASA) and metamizole on arachidonic acid (AA)-induced platelet aggregation over the course of the day.", "results_summary": "The study found that co-medication of ASA and metamizole significantly influences platelet inhibition, with variations during the day, and can cause high on-treatment platelet reactivity (HTPR) in patients taking ASA prior to or simultaneously with metamizole. Maximum AA-induced platelet aggregation was lower in the not recommended dosing group but not in the recommended dosing group.", "population_specificity": "Hospitalized patients (n=36) divided into recommended dosing (n=15), not recommended dosing (n=16), and mixed dosing (n=5) groups.", "effective_dosage": "Not specified", "study_duration": "Measurements taken before, 1-2 hours, and 5-6 hours after intake of ASA \u00b1 metamizole.", "interactions": "Interaction noted between aspirin (ASA) and metamizole affecting AA-induced platelet aggregation.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:59.700653+00:00"}
{"study_id": 110171, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of arachidonic acid metabolism inhibition by omega-3 fatty acids in reducing inflammation and improving insulin sensitivity, particularly in the context of obesity and type 2 diabetes prevention.", "results_summary": "The study found that omega-3 fatty acids, by inhibiting arachidonic acid metabolism and promoting specialized pro-resolving mediators (SPMs), reduce adipose inflammation and enhance insulin sensitivity. However, obesity reduces SPM levels, suggesting a potential deficiency that supplementation may address.", "population_specificity": "Rodent obesity models (with implications for human translation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:59.730228+00:00"}
{"study_id": 110170, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived PGE2 in colorectal cancer tumorigenesis and the therapeutic potential of targeting its downstream EP receptors.", "results_summary": "The study highlights that PGE2, derived from arachidonic acid via COX-2, plays a significant role in CRC development by regulating immune cell functions. Current therapies targeting PGE2 globally (e.g., NSAIDs, COX-2 inhibitors) have adverse effects, suggesting a need for more specific downstream targeting.", "population_specificity": "Colorectal cancer (CRC) patients and tumor microenvironment components (macrophages, neutrophils, fibroblasts).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:00.275842+00:00"}
{"study_id": 110172, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review and clarify the role of lipoxins, derived from arachidonic acid, in neuroinflammation and neurodegeneration, particularly in Alzheimer's disease and retinal injury.", "results_summary": "The study found that lipoxins, derived from arachidonic acid, play a role in resolving inflammation and promoting neuronal survival in retinal and cortical neurons, though results in Alzheimer's disease models were complex and sometimes conflicting.", "population_specificity": "Rodent models of Alzheimer's disease and clinical tissue samples, as well as retinal and cortical neurons.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:00.977980+00:00"}
{"study_id": 110173, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review evidence on the role of linoleic acid (LA) in cardiovascular health, including its metabolism into Arachidonic Acid (AA) and potential effects.", "results_summary": "The study found that high dietary intake of LA (which can metabolize into AA) is associated with improved cardiovascular risk factors, long-term glycemic control, and reduced incidence of cardiovascular diseases and metabolic disorders. The effects of AA-derived eicosanoids, some of which have proinflammatory or prothrombotic-vasoconstrictor actions, were less clear.", "population_specificity": "General population, with focus on cardiovascular and metabolic health outcomes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:01.576976+00:00"}
{"study_id": 110174, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers compared the renoprotective and antioxidant effects of febuxostat and topiroxostat in patients with hyperuricemia and chronic kidney disease (CKD).", "results_summary": "Febuxostat showed stronger renoprotective and antioxidant effects than topiroxostat, with better outcomes in serum creatinine, eGFR, cystatin-C, and Ox-LDL levels.", "population_specificity": "Patients with chronic kidney disease (CKD) and hyperuricemia (eGFR \u226460 mL/min/1.73 m\u00b2).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:02.349807+00:00"}
{"study_id": 110176, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to elucidate the role of CYP-derived eicosanoids, including those from arachidonic acid, in the pathophysiology and protection of inflammatory liver diseases.", "results_summary": "The study found that CYP-derived eicosanoids from arachidonic acid play significant roles in both the progression and protection of inflammatory liver diseases, suggesting potential therapeutic applications.", "population_specificity": "Not specified (general focus on inflammatory liver diseases)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:06.714275+00:00"}
{"study_id": 110175, "supplement_id": 885, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived specialized pro-resolving mediators (SPMs) in blocking pain and infection without immunosuppressive or opioid-related side effects.", "results_summary": "The study found that SPMs, derived from arachidonic acid and other omega-3 fatty acids, show efficacy at very low doses in treating pain and infection in experimental models, with no reported side effects and long-lasting analgesic and anti-inflammatory effects.", "population_specificity": "Experimental models (not specified if human or animal).", "effective_dosage": "Very low doses (specific amount not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:06.792933+00:00"}
{"study_id": 110179, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid and other PUFAs in macrophage functions and their implications in cardiometabolic diseases, particularly atherosclerosis.", "results_summary": "The study found that arachidonic acid and other PUFAs regulate macrophage functions, influence pathological processes like atherosclerosis, and may play a role in cardiometabolic diseases. Purified n-3 FA supplementation was highlighted as a potential strategy for cardiovascular disease treatment and prevention.", "population_specificity": "Myeloid cells and macrophages, with implications for human cardiometabolic diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:08.243184+00:00"}
{"study_id": 110180, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to determine if platelet aggregation responses, including those induced by arachidonic acid, differ in men with diabetes mellitus compared to those without.", "results_summary": "The study found no significant difference in platelet aggregation responses to arachidonic acid between men with and without diabetes mellitus, nor was platelet aggregation associated with glycemic status or coronary atherosclerosis.", "population_specificity": "Men aged 65-74 years, including 110 with diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:08.243878+00:00"}
{"study_id": 110178, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of soluble epoxide hydrolase (sEH) inhibition and epoxy fatty acids (EpFAs) derived from arachidonic acid in neuroinflammatory disorders.", "results_summary": "The study highlights that sEH inhibition enhances the protective effects of EpFAs in neuroinflammatory conditions like Parkinson's Disease, stroke, depression, epilepsy, and Alzheimer's Disease, suggesting potential therapeutic benefits.", "population_specificity": "Neuroinflammatory disorders (e.g., Parkinson's Disease, stroke, depression, epilepsy, Alzheimer's Disease).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:08.397738+00:00"}
{"study_id": 110181, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the suitability and safety of infant formula containing DHA without AA and to recommend optimal DHA and AA levels based on scientific evidence.", "results_summary": "The study found no accountable evidence supporting the safety and suitability of DHA-only infant formula and strongly recommended including AA alongside DHA, with AA content at least matching DHA levels up to ~0.64%. Further clinical studies are needed to define optimal AA intakes.", "population_specificity": "Healthy infants (infant and follow-on formula consumers)", "effective_dosage": "AA should at least equal DHA content (up to ~0.64% of FAs)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:10.287835+00:00"}
{"study_id": 110182, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of 15-LOX-1 (which metabolizes arachidonic acid) in acquired doxorubicin resistance in MCF7 and HeLa cancer cell lines.", "results_summary": "The study found that 15-LOX-1 was downregulated in doxorubicin-resistant cells, and its overexpression resensitized cells to doxorubicin in a cell-dependent manner. In MCF7 cells, 15-LOX-1 expression induced apoptosis and enhanced doxorubicin accumulation, while HeLa cells responded to 13(S)-HODE treatment.", "population_specificity": "MCF7 and HeLa cancer cell lines", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:11.087409+00:00"}
{"study_id": 110183, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether patients with ischemic events had higher platelet reactivity (measured via arachidonic acid-induced aggregation) despite aspirin medication compared to those without ischemic events.", "results_summary": "Patients who suffered from MACCE, death, or NSTEMI showed significantly higher platelet reactivity (measured by maximum aggregation) than those without these events, suggesting insufficient aspirin response as a risk factor for ischemic events. No significant difference was observed for stroke occurrence.", "population_specificity": "72 patients with coronary artery disease (CAD).", "effective_dosage": "Not specified", "study_duration": "Mean follow-up of 3.2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:12.410250+00:00"}
{"study_id": 110184, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify a research goal related to Arachidonic Acid.", "results_summary": "The abstract does not report any findings related to Arachidonic Acid.", "population_specificity": "Not specified (abstract focuses on asthma treatment generally).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:13.180317+00:00"}
{"study_id": 110185, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of eicosanoids derived from the CYP pathway of Arachidonic Acid in inflammatory shock syndromes, particularly septic shock, and explore potential therapeutic strategies targeting specific CYP isoforms.", "results_summary": "The study highlights that Arachidonic Acid-derived eicosanoids, produced via the CYP pathway, play a significant role in inflammatory shock syndromes, including septic shock, by contributing to proinflammatory and anti-inflammatory mediator production. The review suggests targeting specific CYP isoforms could be a therapeutic strategy for these conditions.", "population_specificity": "Animal models of inflammatory shock syndromes, with an emphasis on septic shock.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:16.017357+00:00"}
{"study_id": 110188, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether DHA+AA supplementation improved caregiver-reported sleep in toddlers born preterm and whether child sex, birth weight, or caregiver depressive symptoms moderated the effect.", "results_summary": "The study found no overall effect of DHA+AA supplementation on child sleep, but exploratory analyses suggested potential benefits for specific subgroups of preterm children.", "population_specificity": "Toddlers born preterm (gestation <35 weeks), aged 10-16 months at enrollment.", "effective_dosage": "200 mg AA + 200 mg DHA daily.", "study_duration": "180 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:16.754899+00:00"}
{"study_id": 110186, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid in inflammatory processes related to atherosclerosis and vascular cognitive impairment, and how omega-3 PUFA supplementation might counteract its pro-inflammatory effects.", "results_summary": "The study found that arachidonic acid, as an omega-6 PUFA, contributes to pro-inflammatory eicosanoid production, while omega-3 PUFAs compete with it, reducing inflammation and potentially lowering atherosclerosis and VCID risk.", "population_specificity": "Not specified (general discussion of atherosclerosis and VCID mechanisms).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:16.756427+00:00"}
{"study_id": 110187, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adding eicosapentaenoic acid (EPA) to statin therapy alters HDL heterogeneity and affects the serum EPA/arachidonic acid (AA) ratio as a potential marker for coronary artery disease (CAD).", "results_summary": "The study found that EPA administration significantly decreased serum HDL levels and altered HDL particle size, suggesting an impact on HDL heterogeneity. However, the abstract does not provide detailed outcomes regarding the EPA/AA ratio or CAD risk reduction.", "population_specificity": "Patients with ongoing statin therapy (specific population details not provided).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:17.455327+00:00"}
{"study_id": 110190, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the role of CYP4 enzymes in the metabolism of fatty acids, including Arachidonic Acid, and their implications in biological functions such as inflammation, skin barrier, eye function, cardiovascular health, and cancer.", "results_summary": "The abstract does not provide specific findings about Arachidonic Acid's effects, only that CYP4 enzymes are involved in its metabolism and related biological functions.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:18.900551+00:00"}
{"study_id": 110189, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether the FADS2 genotype (rs1535) modifies the therapeutic response of omega-3 fatty acids (O-3FA) in post-acute myocardial infarction (AMI) cardiac remodeling, particularly focusing on arachidonic acid (ArA) metabolism.", "results_summary": "Patients with the GG genotype of FADS2 showed significant improvements in cardiac remodeling markers (LVESVi, NT-proBNP, and galectin-3) with O-3FA treatment, while AA or AG genotypes did not. The odds of improving LVESVi by 10% were highest in GG patients (OR: 7.2).", "population_specificity": "312 post-AMI patients", "effective_dosage": "High-dose O-3FA (specific amount not stated)", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:20.025653+00:00"}
{"study_id": 110192, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of intermittent versus continuous low-dose aspirin on arachidonic acid metabolism in heavy smokers.", "results_summary": "Low-dose aspirin suppressed urinary prostaglandin E2 metabolite (PGEM) levels, indicating modulation of arachidonic acid metabolism. The study did not report specific outcomes related to arachidonic acid's direct effects.", "population_specificity": "Current heavy smokers", "effective_dosage": "81 mg daily (continuous or intermittent)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:21.093943+00:00"}
{"study_id": 110191, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of arachidonic acid metabolism in microvascular reactivity changes following red blood cell transfusion in anemic ICU patients.", "results_summary": "The study found that patients with improved microvascular reactivity after transfusion had enhanced metabolism of arachidonic acid into vasodilating lipids, suggesting a link between leukocyte activity, arachidonic acid pathways, and vascular response.", "population_specificity": "Anemic patients in a medical ICU requiring red blood cell transfusion (median age 66, SAPS II score 38).", "effective_dosage": "Not specified", "study_duration": "Microvascular reactivity was measured before and 30 minutes after transfusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:21.542912+00:00"}
{"study_id": 110195, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to describe the metabolic pathways of Arachidonic Acid (AA) and its role in inflammatory responses, particularly in the kidney.", "results_summary": "The abstract indicates that AA is metabolized into various inflammatory mediators (PGs, Tx, LTs, HETEs) via COX, LOX, and CYP450 enzymes, with increased PGs and TxA noted in the kidney.", "population_specificity": "Not specified (general biochemical focus).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:24.886187+00:00"}
{"study_id": 110193, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of ticagrelor-monotherapy and ticagrelor-based DAPT on hemostatic system activation, including platelet aggregation triggered by arachidonic acid (MEA-AA).", "results_summary": "Both ticagrelor-monotherapy and ticagrelor-based DAPT significantly reduced MEA-AA at 2 hours, with stronger effects observed for DAPT over 24 hours. The study found comparable impacts on hemostatic system activation between the two treatments.", "population_specificity": "44 volunteers", "effective_dosage": "Loading-dose regimen (specific dosage not detailed)", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:25.410722+00:00"}
{"study_id": 110194, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how the baseline EPA/AA ratio affects clinical outcomes in acute coronary syndrome patients with dyslipidemia, specifically comparing pitavastatin+ezetimibe therapy versus pitavastatin monotherapy.", "results_summary": "The study found that patients with a low EPA/AA ratio had a significantly lower risk of cardiovascular events when treated with pitavastatin+ezetimibe compared to pitavastatin alone, while no such benefit was observed in patients with a high EPA/AA ratio.", "population_specificity": "1734 patients with acute coronary syndrome and dyslipidemia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 years of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:25.695947+00:00"}
{"study_id": 110196, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effect of rosuvastatin plus EPA (including its relationship with arachidonic acid) on stabilizing non-obstructive neoatherosclerotic plaques.", "results_summary": "The study found that higher-dose rosuvastatin plus EPA significantly reduced LDL-C levels and stabilized plaques, with changes in lipid index and macrophage grade negatively correlated with serum EPA/arachidonic acid ratios.", "population_specificity": "50 patients with non-obstructive neoatherosclerotic plaques detected via OCT.", "effective_dosage": "EPA 1,800 mg/day (in combination with rosuvastatin 10 mg/day).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:26.550410+00:00"}
{"study_id": 110197, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of arachidonic acid (AA) in inflammation and asthma via its conversion to leukotrienes by 5-LOX, and to discuss novel 5-LOX inhibitors.", "results_summary": "The abstract highlights that AA is converted by 5-LOX to leukotrienes, which are linked to inflammatory disorders like asthma, and reviews novel 5-LOX inhibitors, their design, and clinical updates.", "population_specificity": "Not specified (general focus on inflammatory disorders like asthma).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:28.717379+00:00"}
{"study_id": 110202, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid metabolites in perpetuating ischemic brain damage post-stroke and their potential as therapeutic targets.", "results_summary": "The abstract mentions arachidonic acid metabolites as pathological mediators that could exacerbate ischemic brain damage, but no specific results on their efficacy or safety are provided.", "population_specificity": "Not specified (general focus on stroke patients and neuroinflammation mechanisms).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:29.354679+00:00"}
{"study_id": 110198, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of supplementing preterm infant formula with arachidonic acid (omega-6) and docosahexaenoic acid (omega-3) to mimic breast milk levels and assess developmental outcomes.", "results_summary": "Supplementation with arachidonic acid and docosahexaenoic acid in preterm infant formula improved visual acuity, but higher docosahexaenoic acid levels did not further enhance clinical or developmental outcomes. The impact on childhood development in extremely preterm infants remains unclear.", "population_specificity": "Preterm infants missing the last trimester of in utero omega-3 fatty acid transfer.", "effective_dosage": "Level found in breast milk of women consuming a western diet (specific amount not stated).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:29.367750+00:00"}
{"study_id": 110201, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the relationship between changes in lipids, including arachidonic acid-containing species, upon pravastatin treatment and their association with cardiovascular risk reduction.", "results_summary": "Arachidonic acid-containing species were positively associated with pravastatin treatment, and the lipid ratio PI(36:2)/PC(38:4) mediated 58% of the treatment effect, predicting cardiovascular benefit independent of LDL-C changes.", "population_specificity": "Subcohort of the LIPID study (n = 4991) with baseline and 1-year follow-up plasma lipid measurements (n = 342).", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:29.959733+00:00"}
{"study_id": 110203, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of LC-PUFA supplementation, including arachidonic acid, in improving visual and neurocognitive functions in PKU patients.", "results_summary": "The study found that DHA supplementation improved DHA status and reduced visual evoked potential P100 wave latency in PKU children, but neurocognitive data were inconclusive regarding arachidonic acid.", "population_specificity": "PKU patients aged from 2 weeks to 47 years, with specific focus on children aged 1-11 years.", "effective_dosage": "Not specified", "study_duration": "Varied from 2 weeks to unspecified longer periods", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:33.269862+00:00"}
{"study_id": 110204, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of the arachidonic acid-prostaglandin cascade in neuroinflammation and its potential as a therapeutic target for pharmacoresistant epilepsy.", "results_summary": "The study identified the arachidonic acid-prostaglandin cascade as an activated pathway in pharmacoresistant epilepsy, which can be modulated in animal models to produce therapeutic effects on seizures and neurological comorbidities.", "population_specificity": "Humans with pharmacoresistant epilepsy and animal models of epilepsy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:33.468836+00:00"}
{"study_id": 110205, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to understand the role of arachidonic acid in eosinophil-mediated inflammatory responses, particularly in severe asthma and aspirin-exacerbated respiratory diseases.", "results_summary": "The study found that arachidonic acid is a precursor for cysteinyl leukotrienes, which are inflammatory mediators produced by eosinophils, and that nasal polyp-derived eosinophils from patients with eosinophilic rhinosinusitis exhibit selectively higher leukotriene D production.", "population_specificity": "Patients with eosinophilic rhinosinusitis and severe asthma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:33.844754+00:00"}
{"study_id": 110207, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to review literature on how lipids or lipid metabolites, including Arachidonic Acid, may influence the risk or progression of Epithelial Ovarian Cancer (EOC).", "results_summary": "The abstract does not provide specific findings on Arachidonic Acid's effects, only mentioning a general review of lipids and ion channels in cancer progression.", "population_specificity": "Epithelial Ovarian Cancer (EOC) patients, particularly those with advanced-stage disease (FIGO III-IV).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:34.241555+00:00"}
{"study_id": 110209, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers were attempting to determine the role of extracellular pH changes in synaptic transmission and presynaptic Ca regulation.", "results_summary": "The abstract mentions that extracellular pH changes may signal neuronal communication and occur during synaptic transmission, but no specific findings about Arachidonic Acid are provided.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:35.799495+00:00"}
{"study_id": 110208, "supplement_id": 885, "safety_score": "85", "efficacy_score": 30, "quality_score": 90, "study_goal": "The researchers aimed to examine the effects of supplementing toddlers born preterm with arachidonic acid (AA) and DHA on growth and adiposity over 180 days.", "results_summary": "The study found no statistically significant differences in growth or adiposity outcomes between the DHA + AA and placebo groups, though post-hoc analyses suggested slower linear growth in females receiving DHA + AA.", "population_specificity": "Toddlers born preterm (<35 weeks gestation), aged 10-16 months in corrected age.", "effective_dosage": "200 mg AA daily (combined with 200 mg DHA).", "study_duration": "180 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:37.082634+00:00"}
{"study_id": 110210, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the roles of leukotrienes derived from arachidonic acid in inflammatory diseases and explore potential clinical applications of their antagonists and biosynthesis inhibitors.", "results_summary": "The study found that arachidonic acid-derived leukotrienes (LTB4 and CysLTs) and their receptors (BLT1, CysLT1/2, GPR99) are involved in acute and chronic inflammatory diseases, including asthma, atopic dermatitis, and cancer, based on animal models and gene knockout studies.", "population_specificity": "Animal models and gene knockout mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:38.486741+00:00"}
{"study_id": 110211, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the role of the EPA:AA ratio as a marker of cardiovascular disease and the relationship between changes in the ratio (mediated by EPA intake) and cardiovascular risk.", "results_summary": "The study found that a lower EPA:AA ratio, indicating higher arachidonic acid levels, is associated with increased cardiovascular risk, including coronary artery disease, acute coronary syndrome, and stroke. Increasing the EPA:AA ratio through purified EPA treatment was effective in reducing cardiovascular risk.", "population_specificity": "Individuals at risk of or with existing cardiovascular disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:39.861005+00:00"}
{"study_id": 110212, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of polyphenols, including their activation of the arachidonic acid-dependent pathway, in modulating immune responses for managing autoimmune disorders.", "results_summary": "Polyphenols, through pathways like arachidonic acid-dependent signaling, show potential as immunomodulatory agents for autoimmune diseases such as vitiligo, ulcerative colitis, and multiple sclerosis, though complete cure remains unproven.", "population_specificity": "General discussion on autoimmune disorders (e.g., Type I diabetes, rheumatoid arthritis, multiple sclerosis) without specific population details.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:41.298661+00:00"}
{"study_id": 110215, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review dietary ARA intake, its effects on LCPUFA metabolism in adult humans, and discuss its nutritional significance.", "results_summary": "The abstract indicates that ARA's biological aspects are well-studied, but nutritional information is limited in adult humans. The review discusses ARA's role in LCPUFA metabolism and its dietary significance.", "population_specificity": "Adult humans", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:41.570433+00:00"}
{"study_id": 110213, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify metabolic differences, including arachidonic acid alterations, in HIV/TB patients with and without TB-IRIS to aid in early diagnosis and understanding of the condition.", "results_summary": "The study found that arachidonic acid metabolism was altered in TB-IRIS patients at study entry, suggesting its potential role in the condition. Sphingolipid and linoleic acid pathways were also significantly affected during the TB-IRIS window.", "population_specificity": "HIV/TB patients (n=26 with TB-IRIS, n=22 without TB-IRIS) from the ACTG A5221 study.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:42.660207+00:00"}
{"study_id": 110214, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to quantify the dose-response relationship between EPA and DHA intake and plasma oxylipin concentrations, including changes in arachidonic acid-derived oxylipins.", "results_summary": "The study found that EPA and DHA intake linearly increased plasma concentrations of n-3 PUFA-derived oxylipins, including anti-inflammatory and cardioprotective epoxy-PUFAs, while moderately decreasing arachidonic acid-derived oxylipins. Interindividual variability in plasma concentrations was low.", "population_specificity": "Healthy adult men and women with low habitual fish consumption (n=121).", "effective_dosage": "Capsules providing 3.27 g EPA + DHA (1:1.2, wt:wt) per portion, reflecting 1, 2, or 4 portions of oily fish per week.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:44.198458+00:00"}
{"study_id": 110216, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of cardiac metabolism, including the processing of arachidonic acid metabolites, in regulating heart homeostasis and its susceptibility to xenobiotics.", "results_summary": "The study identified that cardiac P450 enzymes produce hydroxyeicosatetraneoic acids and epoxyeicosatrienoic acids from arachidonic acid, which are critical for heart homeostasis, but noted knowledge gaps in the susceptibility of these pathways to disruption by xenobiotics.", "population_specificity": "Not specified (general discussion of cardiac metabolism across potential patient demographics).", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:44.208579+00:00"}
{"study_id": 110217, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the roles of prostaglandin E2 (PGE2) receptors, derived from arachidonic acid, in inflammation and autoimmune diseases.", "results_summary": "PGE2 exacerbates acute inflammation via EP3 receptor-mediated mast cell activation and chronic inflammation/autoimmune diseases through EP2/EP4 receptor-mediated Th1/Th17/Th22 cell responses. Non-steroidal anti-inflammatory drugs (NSAIDs) suppress PGE2 production by inhibiting COX activity.", "population_specificity": "Animal models (mice deficient in PG receptor subtypes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "NSAIDs (e.g., aspirin, indomethacin) inhibit PGE2 production.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:47.341920+00:00"}
{"study_id": 110220, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived pro-resolving mediators in resolving inflammation and their potential therapeutic impact on atherosclerotic lesion progression.", "results_summary": "The study found that arachidonic acid-derived pro-resolving mediators contribute to inflammation resolution by converting pro-inflammatory macrophages into anti-inflammatory ones, but their levels are low in advanced atherosclerotic lesions, impairing resolution.", "population_specificity": "Not specified (general discussion of atherosclerotic mechanisms).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:47.392095+00:00"}
{"study_id": 110219, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to summarize current knowledge about the GPCR GPR31/12-HETER, particularly its structural similarity to human homologs and the biological functions of its ligand 12(S)-HETE (a derivative of Arachidonic Acid).", "results_summary": "The abstract highlights the structural similarity of GPR31/12-HETER to human homologs and discusses the biological functions of its ligand 12(S)-HETE, but does not provide specific findings on Arachidonic Acid's effects.", "population_specificity": "Not specified (minireview of existing literature).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:47.395825+00:00"}
{"study_id": 110221, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the utility of pharmacometabolomics in detecting zonisamide metabolites, including phosphatidylcholines with 20:4 FA (arachidonic acid), related to its disposition, efficacy, and toxicity.", "results_summary": "The study identified phosphatidylcholines with 20:4 FA (arachidonic acid) as one of the metabolites linked to zonisamide's pharmacokinetic parameters, but no specific effects or outcomes related to arachidonic acid were detailed.", "population_specificity": "28 healthy volunteers", "effective_dosage": "Not specified for arachidonic acid", "study_duration": "Single dose of zonisamide administered on two separate occasions with a washout period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:50.205136+00:00"}
{"study_id": 110222, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of arachidonic acid-derived lipid mediators, such as PGE2 and PGD2, in chronic stress-induced emotional alterations and depression-like behavior in rodent models.", "results_summary": "The study found that arachidonic acid-derived mediators like PGE2 and PGD2 play roles in depression-like behavior induced by chronic stress, with PGE2 attenuating prefrontal dopaminergic activity and PGD2 showing mixed pro-depressive or anti-depressive effects. Additionally, chronic stress upregulates enzymes involved in arachidonic acid metabolism, contributing to neuroinflammation-associated depression.", "population_specificity": "Rodent models (chronic stress-induced depression)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:50.833111+00:00"}
{"study_id": 110223, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the reversal of ticagrelor's antiplatelet effects using donor platelets and explore the impact of residual ticagrelor on donor platelets.", "results_summary": "The study found that the antiplatelet effect of ticagrelor could not be fully reversed by donor platelets, likely due to the presence of active drug. Residual drug effects on donor platelets were evident for at least 10 hours after ticagrelor ingestion.", "population_specificity": "Healthy subjects", "effective_dosage": "Ticagrelor 90 mg twice daily, aspirin 100 mg once daily, clopidogrel 75 mg once daily", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:51.406218+00:00"}
{"study_id": 110225, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the differences in PUFA levels, including arachidonic acid, between patients with eating disorders and healthy controls, and assess potential benefits of PUFAs in such patients.", "results_summary": "The study found that patients with eating disorders had significantly lower levels of arachidonic acid in red blood cell membranes compared to healthy controls. PUFA supplements showed benefits for body weight outcomes but not for disease severity or mood symptoms.", "population_specificity": "379 patients with eating disorders compared to healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:52.091652+00:00"}
{"study_id": 110226, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived endocannabinoids in atherosclerosis and metabolic complications, focusing on their pathophysiological effects and therapeutic potential.", "results_summary": "The study found that elevated endocannabinoid levels, derived from arachidonic acid, contribute to vascular inflammation, leukocyte recruitment, and macrophage cholesterol metabolism, impacting atherosclerotic plaque stability. Targeting the endocannabinoid system may offer therapeutic benefits by reducing vascular inflammation and improving metabolic risk factors.", "population_specificity": "Not specified (general discussion of metabolic disease models and atherosclerosis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:53.672498+00:00"}
{"study_id": 110228, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 82, "study_goal": "The researchers aimed to analyze the clinical and prognostic effects of COX-2 protein expression, a key enzyme in arachidonic acid metabolism, in osteosarcoma patients.", "results_summary": "The study found that COX-2 protein expression was significantly higher in osteosarcoma compared to benign osteochondroma (OR = 7.66), suggesting its potential role in malignancy. The analysis included 23 studies with 1084 osteosarcoma patients, indicating a robust association.", "population_specificity": "Patients with malignant osteosarcoma (1084) and benign osteochondroma (247).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:56.199943+00:00"}
{"study_id": 110229, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the pharmacodynamics of very-low-dose twice-daily aspirin (20 mg BD) with standard-dose once-daily aspirin (75 mg OD) in combination with ticagrelor for ACS patients.", "results_summary": "The study found that very-low-dose aspirin (20 mg BD) combined with ticagrelor showed potential for reducing bleeding risk while maintaining antithrombotic benefits, as measured by serum thromboxane (TX)B levels.", "population_specificity": "20 ticagrelor-treated acute coronary syndrome (ACS) patients.", "effective_dosage": "Aspirin 20 mg twice-daily (BD) and 75 mg once-daily (OD).", "study_duration": "14 days per treatment period (crossover design).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:57.154942+00:00"}
{"study_id": 110230, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers explored the role of COX-2, an enzyme involved in converting arachidonic acid to prostaglandins, in gastrointestinal cancers and its potential as a therapeutic target.", "results_summary": "The study found that COX-2, upregulated in GI malignancies, contributes to cancer progression by promoting cell proliferation, angiogenesis, and antiapoptotic activity, suggesting COX-2 inhibitors could be a promising treatment strategy.", "population_specificity": "Gastrointestinal (GI) malignancies", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:57.956080+00:00"}
{"study_id": 110227, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether noradrenaline (NA) enhances platelet aggregation, including responses to arachidonic acid (AA), in patients undergoing coronary artery bypass grafting (CABG).", "results_summary": "Low-dose noradrenaline improved intraoperative platelet aggregation (measured via impedance aggregometry with AA as an initiator) and clot formation in CABG patients. The treatment group maintained mean arterial blood pressure with NA infusion, showing enhanced hemostatic effects compared to controls.", "population_specificity": "24 patients undergoing CABG, most of whom were treated with acetylsalicylic acid (ASA).", "effective_dosage": "Median NA dose after 50 min was 0.09 (range 0-0.26) \u03bcg/kg. AA dosage not specified.", "study_duration": "Assessed before and 50 min after anesthesia induction (pre-cardiopulmonary bypass).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:58.082097+00:00"}
{"study_id": 110231, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the role of acid-sensing ion channels (ASICs) in response to local pH changes under physiological and pathological conditions.", "results_summary": "The abstract mentions that ASICs are activated by low pH, which occurs temporarily in synapses during neuronal activity and persistently in pathological conditions like ischemia, inflammation, and tumor growth. No specific findings about Arachidonic Acid are provided.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:59.107058+00:00"}
{"study_id": 110233, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to examine the relationship between serum arachidonic acid (AA) levels, EPA/AA ratio, and weight loss effectiveness in overweight patients with type 2 diabetes during hospitalization.", "results_summary": "The study found no significant association between serum AA levels and effective weight loss (HR 1.11, P=0.82), but the EPA/AA ratio was a better predictor of weight loss than serum EPA alone.", "population_specificity": "142 hospitalized overweight patients with type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Duration of hospitalization (not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:01.053373+00:00"}
{"study_id": 110234, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the roles of arachidonic acid-derived eicosanoids in tissue repair during homeostasis and disease, and explore their potential therapeutic targeting.", "results_summary": "The study found that eicosanoids play central roles in regulating tissue repair, with distinct functions in epithelial barrier repair and pathological conditions like chronic wounds and fibrosis. It highlighted their time-, cell-, and tissue-dependent production during damage and repair.", "population_specificity": "Not specified (general tissue repair mechanisms in homeostasis and disease contexts).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:01.404798+00:00"}
{"study_id": 110235, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of fish oil supplementation on urinary and rectal eicosanoid levels, particularly focusing on arachidonic acid-related pathways, in individuals with a history of colorectal adenomas.", "results_summary": "Fish oil supplementation reduced urinary PGE-M production compared to olive oil but did not significantly reduce rectal PGE2 overall, except in participants not using aspirin or NSAIDs. The FADS1 genotype did not influence the effects of fish oil on PGE2 production.", "population_specificity": "Individuals with a history of colorectal adenomas.", "effective_dosage": "2.5 g of fish oil per day.", "study_duration": "6 months.", "interactions": "Reduced efficacy in participants using aspirin or NSAIDs.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:04.826771+00:00"}
{"study_id": 110237, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether digoxin affects cardiovascular risk by increasing platelet activation in anticoagulated patients with atrial fibrillation.", "results_summary": "The study compared digoxin users and nonusers, balanced for age, sex, and cardiovascular risk factors, but did not report specific findings related to Arachidonic Acid.", "population_specificity": "Anticoagulated patients with atrial fibrillation (digoxin users: n=132; nonusers: n=388).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:04.966074+00:00"}
{"study_id": 110236, "supplement_id": 885, "safety_score": "20", "efficacy_score": 15, "quality_score": 85, "study_goal": "The researchers aimed to assess the association between dietary fat intake, including arachidonic acid, and total and cause-specific mortality.", "results_summary": "The study found that arachidonic acid intake was associated with higher total mortality (HR 1.10, 95% CI 1.08-1.13) and positively associated with cardiovascular disease mortality. These results suggest adverse effects of arachidonic acid on health outcomes.", "population_specificity": "521,120 participants aged 50 to 71 years from the NIH-AARP Diet and Health Study.", "effective_dosage": "Not specified", "study_duration": "16 years of follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:05.395543+00:00"}
{"study_id": 110238, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the renoprotective effects of CYP450 epoxygenase metabolites of arachidonic acid (EETs) in kidney physiology and diseases.", "results_summary": "The study found that EETs, derived from arachidonic acid, exhibit renoprotective effects through vasodilation, anti-hypertension, anti-apoptosis, and anti-inflammation, but their production is reduced in renal diseases. Increasing EETs via transgenic overexpression or soluble epoxide hydrolase inhibitors showed protective effects in vivo.", "population_specificity": "Renal microvasculature in animal models (transgenic animals).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:06.671674+00:00"}
{"study_id": 110239, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the role of arachidonic acid metabolites in Duchenne muscular dystrophy (DMD) and explore new drug development opportunities by targeting the AA pathway.", "results_summary": "The study suggests that targeting arachidonic acid metabolites could be an effective strategy to improve treatment for DMD patients, with specific focus on 5-LOX inhibition, H-PGDS inhibitors, and COX-inhibiting NO donors (CINODs).", "population_specificity": "Patients with Duchenne muscular dystrophy (DMD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:07.708453+00:00"}
{"study_id": 110240, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether DHA supplementation (derived from alpha-linolenic acid, a precursor to arachidonic acid) could improve plasma DHA levels and neurological/intellectual functioning in children with PKU.", "results_summary": "DHA supplementation increased plasma DHA levels proportionally to dosage but did not improve neurological or intellectual functioning. Genotypes influenced plasma arachidonic acid levels and, when combined with precursor levels, also affected DHA, but supplementation effects were not significantly associated with genotype.", "population_specificity": "Children with phenylketonuria (PKU)", "effective_dosage": "0 to 7 mg/kg/day", "study_duration": "Six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:09.379429+00:00"}
{"study_id": 110241, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of P450-mediated arachidonic acid metabolites (subterminal HETEs) in physiological and pathophysiological conditions, and their potential as therapeutic targets in various diseases.", "results_summary": "The study found that P450 enzymes metabolize arachidonic acid into biologically active subterminal HETEs, which play significant roles in organs like the kidneys, heart, liver, and brain, and are implicated in diseases such as hypertension, acute coronary syndrome, and inflammatory conditions. The review also highlighted the stereoselectivity of these metabolites and their potential as novel therapeutic targets.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:10.420300+00:00"}
{"study_id": 110232, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of seafood intake, including potential roles of marine n-3 PUFAs (like Arachidonic Acid derivatives), on obesity, insulin resistance, and type 2 diabetes.", "results_summary": "Lean seafood intake reduced energy intake by 4-9%, improved insulin sensitivity, and increased adiponectin levels, while fatty seafood showed mixed effects on inflammatory markers. Marine n-3 PUFAs and other seafood constituents may contribute to these benefits.", "population_specificity": "Insulin-resistant adults and general populations studied for obesity and metabolic health.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:10.663587+00:00"}
{"study_id": 110242, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of cerebral CYP isoforms, including their involvement in the metabolism of arachidonic acid, and their potential impact on brain function and disease.", "results_summary": "The study highlights that cerebral CYP enzymes, including those metabolizing arachidonic acid, may influence brain development, mental and neurodegenerative diseases, and the therapeutic effects of psychoactive drugs. However, specific findings on arachidonic acid's effects are not detailed.", "population_specificity": "Not specified (focus on cerebral CYP isoforms and their general role in brain metabolism).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:13.189449+00:00"}
{"study_id": 110244, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the pathophysiology and heterogeneity of NSAID-Exacerbated Disease (N-ERD), including the role of arachidonic acid metabolism abnormalities.", "results_summary": "The study found that N-ERD is a heterogeneous syndrome with complex pathophysiology extending beyond arachidonic acid metabolism, influencing treatment response variability.", "population_specificity": "Patients with asthma and/or rhinosinusitis with nasal polyps who experience NSAID-exacerbated symptoms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:13.228620+00:00"}
{"study_id": 110245, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of increasing omega-6 fats, including arachidonic acid (AA), on cardiovascular disease (CVD) and all-cause mortality.", "results_summary": "The study did not specifically assess the effects of arachidonic acid (AA) as no trials included AA supplementation; the focus was primarily on linoleic acid (LA) and gamma-linolenic acid (GLA).", "population_specificity": "Adults with or without CVD.", "effective_dosage": "Not specified for AA.", "study_duration": "1 to 8 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:14.841447+00:00"}
{"study_id": 110243, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the association between midlife intake of unsaturated fatty acids, including arachidonic acid, and cognitive performance 13 years later, and to test if antioxidant supplementation modulated this effect.", "results_summary": "Arachidonic acid showed a detrimental effect on cognitive functioning in the placebo group, with higher intake associated with worse performance. No significant negative effect was observed in the antioxidant-supplemented group.", "population_specificity": "3,362 French adults (mean age 65.5 \u00b1 4.6 years) from the SU.VI.MAX study.", "effective_dosage": "Not specified", "study_duration": "8 years (1994-2002) for antioxidant intervention; cognitive assessment 13 years after baseline.", "interactions": "Antioxidant supplementation appeared to mitigate the negative cognitive effects of arachidonic acid.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:15.215391+00:00"}
{"study_id": 110247, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of eicosanoids derived from arachidonic acid in physiological and pathological kidney conditions, including acute kidney injury (AKI) and chronic kidney disease (CKD).", "results_summary": "The study found that eicosanoids derived from arachidonic acid play a significant role in kidney-related physiological and pathological processes, including inflammation and oxidative stress, and may serve as biomarkers for kidney diseases. However, their exact role remains unclear and requires further investigation.", "population_specificity": "Not specified (general discussion of kidney-related conditions).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:16.545803+00:00"}
{"study_id": 110249, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the biosynthesis of prostaglandins from arachidonic acid via the COX pathway.", "results_summary": "The abstract describes the role of arachidonic acid in prostaglandin synthesis but does not report specific effects or outcomes related to its supplementation.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:17.965492+00:00"}
{"study_id": 110248, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the role of soluble epoxide hydrolase (sEH) in CNS disorders and the therapeutic potential of sEH inhibitors, which affect the arachidonic acid pathway.", "results_summary": "The study found that sEH inhibition increases anti-inflammatory EETs, showing therapeutic potential in cardiovascular, renal, and CNS disorders, including stroke, Parkinson's, and depression. Combining sEH inhibitors with stem cell therapy may enhance treatment efficacy for CNS disorders.", "population_specificity": "Not specified (review of existing research on CNS disorders).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:18.098645+00:00"}
{"study_id": 110250, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate changes in serum fatty acid profiles, including arachidonic acid, and their association with attention scores and tolerability in ADHD children treated with methylphenidate and \u03c9-3 PUFAs.", "results_summary": "The study found a significant decrease in arachidonic acid levels (P<0.0259) alongside improved attention scores and ADHD symptom reduction. No severe side effects were reported.", "population_specificity": "40 children with ADHD, aged 7-15 years.", "effective_dosage": "Not specified for arachidonic acid (only EPA 70 mg/day + DHA 250 mg/day mentioned).", "study_duration": "1 month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:20.411245+00:00"}
{"study_id": 110252, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of arachidonic acid-derived cysteinyl leukotrienes (cysLTs) and their receptors in neurodegenerative disorders, particularly Alzheimer's disease (AD).", "results_summary": "The abstract highlights that cysLTs, produced from arachidonic acid, are implicated in inflammatory processes linked to AD and other neurodegenerative diseases, but clinical data on their role in AD is limited. It also reviews the potential of cysLT inhibitors as a future therapeutic approach for AD.", "population_specificity": "Not specified (review of existing literature on neurodegenerative disorders, including AD).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:21.752475+00:00"}
{"study_id": 110251, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether simvastatin's platelet-inhibiting effects correlated with its impact on arachidonic acid (AA)-induced platelet aggregation and other inflammatory markers in hypercholesterolemic patients.", "results_summary": "Simvastatin treatment significantly reduced platelet aggregation induced by AA (p=0.003) and enhanced the antiaggregating effect of aspirin in the presence of AA (p=0.0001). The study also noted reductions in inflammatory markers and improved endothelial dysfunction.", "population_specificity": "Hypercholesterolemic patients (n=25 treated with simvastatin, n=20 diet-only controls).", "effective_dosage": "40 mg simvastatin daily.", "study_duration": "2 months.", "interactions": "Enhanced antiaggregating effect of aspirin in the presence of AA.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:22.852527+00:00"}
{"study_id": 110253, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether obstructive sleep apnea (OSA) affects platelet function profiles, including the inhibitory rate of the arachidonic acid pathway, in acute coronary syndrome (ACS) patients taking dual antiplatelet therapy.", "results_summary": "The study found that ACS patients with OSA had significantly increased platelet volume indices and reduced clopidogrel-induced antiplatelet effects, but the inhibitory rate of the arachidonic acid pathway was not explicitly highlighted in the results.", "population_specificity": "ACS patients taking maintenance aspirin and clopidogrel therapy (n=127).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:23.220001+00:00"}
{"study_id": 110254, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 71, "quality_score": 68, "study_goal": "The researchers aimed to compare the diagnostic performance of multiple electrode aggregometry (MEA) with light transmission aggregometry (LTA) in detecting platelet aggregation abnormalities using arachidonic acid (AA) and other agonists.", "results_summary": "MEA showed moderate sensitivity (0.71) and high specificity (0.85) for detecting abnormal AA responses compared to LTA, with a favorable negative predictive value (0.93), suggesting MEA may be useful for screening platelet dysfunction. However, specific MEA abnormalities did not reliably predict LTA abnormalities.", "population_specificity": "99 patients (66 female, 33 male; median age 26, range 2-86 years) referred for evaluation of mucocutaneous bleeding.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:24.534004+00:00"}
{"study_id": 110255, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether daily supplementation with Arachidonic Acid (AA) and DHA improves developmental outcomes in toddlers born preterm.", "results_summary": "The study found no improvement in cognitive development with AA+DHA supplementation and noted potential negative effects on language development and effortful control in certain subgroups. Motor scores and activity levels were unaffected.", "population_specificity": "Toddlers born at less than 35 weeks' gestation, aged 10-16 months corrected age.", "effective_dosage": "200 mg AA and 200 mg DHA daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:24.692200+00:00"}
{"study_id": 110257, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify metabolic pathways, including arachidonic acid metabolism, associated with achieving sustained drug-free remission in early rheumatoid arthritis patients treated with tocilizumab or methotrexate.", "results_summary": "The study found that arachidonic acid metabolism was the most significant pathway in the tocilizumab strategy, suggesting its role in therapeutic response. The metabolic profiles differed between treatment arms, indicating treatment-specific interactions affecting remission.", "population_specificity": "Newly diagnosed rheumatoid arthritis patients (n=60) from the U-Act-Early trial.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Tocilizumab inhibits interleukin-6 signaling, which interacts with arachidonic acid metabolism.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:26.556203+00:00"}
{"study_id": 110256, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of 12-LOX in metabolizing arachidonic acid and its impact on inflammation during diabetes development, as well as potential interventions to limit pro-inflammatory metabolites.", "results_summary": "The study found that 12-LOX plays a critical role in modulating inflammation in diabetes and that inhibiting its pro-inflammatory metabolites, either through isoform-specific inhibitors or dietary interventions, could improve health outcomes for diabetic patients. However, developing specific inhibitors has been challenging due to LOX family homology.", "population_specificity": "Patients with type 1 and type 2 diabetes (human and mouse models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:27.350252+00:00"}
{"study_id": 110259, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore new multitargeted pharmacological strategies for modulating the arachidonic acid cascade to develop safer and more effective anti-inflammatory therapeutics.", "results_summary": "The study highlights the complexity of the arachidonic acid cascade, noting that not all its products are pro-inflammatory, and proposes multitargeted interventions (e.g., inhibiting multiple enzymes or blocking selective receptors) to minimize side effects while maintaining efficacy.", "population_specificity": "Not specified (review article, no specific population studied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:29.474146+00:00"}
{"study_id": 110258, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the degree of platelet inhibition via the arachidonic acid (AA) pathway in children after congenital heart surgery, comparing those who received ketorolac versus those who did not.", "results_summary": "The study found that all children who received ketorolac exhibited platelet inhibition via the AA pathway, while nearly all (91.7%) of those who did not receive ketorolac had normal platelet function. The results were statistically significant (P < .0001).", "population_specificity": "Children (mean age 6.6 years, range 0.07-16.7) who underwent congenital heart surgery with cardiopulmonary bypass.", "effective_dosage": "Not specified", "study_duration": "TEG-PM was evaluated pre-surgery and 12-48 hours post-CPB.", "interactions": "Ketorolac (platelet inhibition via AA pathway)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:29.959579+00:00"}
{"study_id": 110261, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize the fatty acid (FA) status of dialysis patients (DP), compare blood FA composition between healthy controls and DP, and evaluate FA profiles and clinical endpoints in DP.", "results_summary": "The abstract does not provide specific findings regarding Arachidonic Acid's effects, only mentioning that moderate to high levels of FAs were observed in dialysis patients.", "population_specificity": "Dialysis patients (hemodialysis and peritoneal dialysis) from various countries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:30.651002+00:00"}
{"study_id": 110263, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential therapeutic effects of ginger and its components, including their impact on arachidonic acid-derived mediators, in the treatment of multiple sclerosis (MS).", "results_summary": "The study suggests that ginger and its components may down-regulate arachidonic acid-derived mediators, among other mechanisms, to exert anti-inflammatory, immunomodulatory, and anti-oxidative effects in MS. The review highlights these properties but calls for further investigation to confirm therapeutic potential.", "population_specificity": "Multiple sclerosis (MS) patients (theoretical, as this is a review paper).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:33.937142+00:00"}
{"study_id": 110262, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of montelukast, a drug targeting the 5-LOX pathway of arachidonic acid metabolism, for preventing and treating abdominal aortic aneurysm (AAA).", "results_summary": "The study suggests that montelukast, a CysLT1 receptor antagonist, may be effective for AAA prevention and treatment, highlighting its potential as a pharmacological intervention for this life-threatening vascular disease. The abstract notes that lukasts like montelukast are safe and well-tolerated for long-term use.", "population_specificity": "Not specified (implied focus on AAA patients or at-risk populations).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:34.057376+00:00"}
{"study_id": 110260, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate strategies to prevent the drug-drug interaction between dipyrone and aspirin in coronary artery disease (CAD) patients, focusing on arachidonic acid (AA)-induced platelet reactivity.", "results_summary": "The study found that dipyrone co-medication was associated with high on-treatment platelet reactivity (HTPR) to aspirin, with incidence varying by dose and administration form. A strict order of intake (aspirin 30 minutes before dipyrone) restored aspirin's antiplatelet effects in all patients.", "population_specificity": "80 CAD patients (mean age 75.5 years, 54% male, 27.5% obese, 47.5% diabetics).", "effective_dosage": "Dipyrone doses varied (<1 g/day to >3 g/day).", "study_duration": "Re-evaluation after 5 days in patients with HTPR.", "interactions": "Dipyrone co-medication impaired aspirin's antiplatelet effects, but timing of administration mitigated this interaction.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:34.419404+00:00"}
{"study_id": 110264, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of different diets and physical activity programs on the AA/EPA ratio in erythrocyte membranes of patients with NAFLD.", "results_summary": "The study found that aerobic activity alone significantly reduced the AA/EPA ratio after 90 days, while combining physical activity with a Low Glycemic Index Mediterranean Diet (LGIMD) was more effective at 45 days, though the effect was not sustained. The combined approach improved steatosis scores.", "population_specificity": "142 subjects with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:34.539395+00:00"}
{"study_id": 110266, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of EPA administration on serum sTM levels and the EPA/AA ratio in CAD patients receiving statin therapy.", "results_summary": "The study found that EPA administration significantly increased sTM levels and the EPA/AA ratio, suggesting a potential association between increased sTM levels and the EPA/AA ratio in CAD patients on statins. The increase in sTM may reflect enhanced TM expression rather than endothelial damage.", "population_specificity": "Stable CAD patients already receiving statin therapy (n=100, split into EPA and control groups).", "effective_dosage": "1800 mg/day of EPA.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:36.049105+00:00"}
{"study_id": 110268, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the potential role of leukotriene receptor antagonists (derived from arachidonic acid cascade) in reducing cardiovascular and cerebrovascular events.", "results_summary": "Animal studies consistently showed that leukotriene receptor antagonists reduced risks of myocardial infarction, ischemic stroke, or atherosclerosis. Two human clinical trials suggested similar benefits, particularly with montelukast.", "population_specificity": "Animals (26 studies) and humans (2 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:37.491867+00:00"}
{"study_id": 110269, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of arachidonic acid metabolites in platelet function and their potential implications in cancer and metastasis.", "results_summary": "The study found that arachidonic acid metabolites, prostacyclin and thromboxane, play a key role in platelet homeostasis, while tumor cells produce more stable prostaglandin E.", "population_specificity": "Not specified (abstract only).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:37.851353+00:00"}
{"study_id": 110267, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of prostaglandins and related lipid mediators, including those derived from arachidonic acid, in the induction and resolution of inflammation in Lyme borreliosis.", "results_summary": "The study found elevated levels of prostaglandins and other lipid mediators in Lyme disease, suggesting their involvement in disease development and persistent inflammation, particularly in cases like Lyme meningitis and antibiotic-refractory Lyme arthritis.", "population_specificity": "Cell-culture studies, animal models, and human subjects with Lyme disease (including Lyme meningitis and Lyme arthritis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:37.855594+00:00"}
{"study_id": 110271, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived eicosanoids in cancer development and metastasis, particularly their interaction with MMPs in the tumor microenvironment.", "results_summary": "The abstract highlights that eicosanoids derived from arachidonic acid and MMPs are both involved in cancer progression and metastasis, but their interrelation remains understudied. The review suggests potential crosstalk between these molecules as a novel therapeutic approach.", "population_specificity": "Not specified (theoretical or general cancer-related mechanisms)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:41.909000+00:00"}
{"study_id": 110270, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review recent advances in understanding the leukotriene-synthesizing enzyme machinery involving arachidonic acid and explore pharmacological intervention opportunities.", "results_summary": "The abstract highlights that leukotrienes, derived from arachidonic acid, play roles in inflammatory diseases and low-grade inflammation, with potential implications for cardiovascular, neurodegenerative, metabolic diseases, and cancer. It also discusses the assembly of biosynthetic enzymes in immune cells and emerging pharmacological strategies.", "population_specificity": "Not specified (focus on mechanistic and pharmacological review).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:42.249432+00:00"}
{"study_id": 110273, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the role of 20-HETE, a metabolite of arachidonic acid, in vascular and cardiac function and its contribution to related diseases.", "results_summary": "Elevated levels of 20-HETE were associated with hypertension, obesity, metabolic syndrome, myocardial infarction, stroke, and chronic kidney diseases. Animal models with increased 20-HETE production showed hypertension and greater susceptibility to cardiovascular injury.", "population_specificity": "Human clinical studies and animal models.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:42.431937+00:00"}
{"study_id": 110274, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of increasing omega-6 fats, including arachidonic acid (AA), on cardiovascular disease (CVD) and all-cause mortality.", "results_summary": "The study did not specifically assess the effects of arachidonic acid (AA) as no trials included AA supplementation; the focus was primarily on linoleic acid (LA) and gamma-linolenic acid (GLA).", "population_specificity": "Adults with or without CVD.", "effective_dosage": "Not specified for AA.", "study_duration": "1 to 8 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:43.006904+00:00"}
{"study_id": 110275, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were investigating the potential inflammatory response induced by Arachidonic Acid metabolism during radiotherapy.", "results_summary": "The abstract mentions the activation of enzymes involved in membrane lipid metabolism, specifically the eicosanoid pathway associated with cPLA2, but does not provide specific findings on Arachidonic Acid's effects.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:44.312863+00:00"}
{"study_id": 110276, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the therapeutic potential of targeting the cytochrome P450 (CYP) pathway of arachidonic acid metabolism, particularly focusing on soluble epoxide hydrolase (sEH) inhibitors and epoxyeicosatrienoic acids (EET) analogs for cardiovascular and renal diseases.", "results_summary": "The study found that sEH inhibitors and EET analogs show promise in preclinical and human studies for treating cardiovascular and renal diseases, with some advancing to clinical trials. However, challenges remain in drug development for this pathway.", "population_specificity": "Preclinical animal models and human studies (specific population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:45.848071+00:00"}
{"study_id": 110277, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore how endogenous signaling lipids, including arachidonic acid, modulate physiological aspects of secretion and membrane fusion.", "results_summary": "The study found that arachidonic acid interacts with SNARE proteins and directly influences the frequency and mode of fusion events, suggesting it plays a regulatory role beyond structural functions in cellular membranes.", "population_specificity": "Not specified (likely in vitro or animal models based on context).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:45.849667+00:00"}
{"study_id": 110278, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the roles of the EP2 receptor, a metabolite of arachidonic acid, in tumor development and its signaling pathway in cancer.", "results_summary": "The study found that EP2 receptor activation influences tumor development through mechanisms like immunity, chronic inflammation, angiogenesis, metastasis, and multidrug resistance, suggesting its potential as a therapeutic target.", "population_specificity": "Not specified (broad review of EP2 receptor roles in cancer)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:46.014942+00:00"}
{"study_id": 110279, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of arachidonic acid-derived prostaglandins, particularly PGE2, in maintaining gastrointestinal mucosal integrity and healing, and their receptor-mediated mechanisms.", "results_summary": "The study found that PGE2, derived from arachidonic acid, plays a protective role in various gastrointestinal conditions by acting through specific EP receptors, modulating functions like mucus secretion, motility inhibition, and immune response downregulation, with COX-1 and COX-2 isoforms differentially involved in mucosal protection and healing.", "population_specificity": "Not specified (likely animal or in vitro models based on context).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:50.245334+00:00"}
{"study_id": 110281, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the functional aspects of the PNPLA3 protein and its role in liver lipid metabolism to inform future therapies for liver disease.", "results_summary": "The study reviewed data showing PNPLA3 has lipase activity on triglycerides and retinyl esters and acyltransferase activity on phospholipids, but the exact mechanism linking PNPLA3 to liver disease remains unclear.", "population_specificity": "Not specified (review of in vitro and in vivo experiments).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:51.089645+00:00"}
{"study_id": 110282, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived eicosanoids in hepatocellular carcinoma (HCC) progression, focusing on mechanisms like cell proliferation, angiogenesis, migration, and apoptosis.", "results_summary": "The study found that eicosanoids derived from arachidonic acid play crucial roles in chronic inflammation and HCC progression, supported by epidemiological, clinical, and basic science evidence. It also described analytical methods and biochemistry related to eicosanoids.", "population_specificity": "Not specified (general focus on hepatocellular carcinoma progression)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:51.686206+00:00"}
{"study_id": 110283, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of prostaglandins, derived from arachidonic acid, in tumor malignancies and the tumor microenvironment.", "results_summary": "The study highlights that prostaglandins, metabolites of arachidonic acid, are abundantly produced in tumor tissues and play a significant role in tumor malignancies, with nonsteroidal anti-inflammatory drugs showing anti-tumor effects by inhibiting prostaglandin production. However, most subsequent research focused narrowly on prostaglandin E, leaving broader implications of arachidonic acid metabolites understudied.", "population_specificity": "Tumor cells and the tumor microenvironment (including endothelial and immune cells).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:51.943543+00:00"}
{"study_id": 110284, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived eicosanoids in inflammation-mediated carcinogenesis and how targeting these pathways could improve cancer prevention and treatment.", "results_summary": "The study found that eicosanoids derived from arachidonic acid promote carcinogenesis by influencing cancer cells and the tumor microenvironment, with thrombospondin-1 playing a regulatory role in these inflammatory pathways. Targeting these interactions may offer new strategies for cancer prevention and therapy.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:52.197741+00:00"}
{"study_id": 110286, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of 5-LOX activity, particularly its involvement in arachidonic acid metabolism, in gastrointestinal cancer progression and its potential as a therapeutic target.", "results_summary": "The study found that targeting the 5-LOX pathway in GI cancer cells showed antiproliferative and proapoptotic effects, suggesting a potential role in cancer treatment. Pharmacogenetic discoveries also highlighted a heritable basis for the leukotriene pathway, offering insights into GI cancer pathogenesis.", "population_specificity": "Gastrointestinal (GI) cancer cells (in vitro or animal models, not explicitly specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:54.197109+00:00"}
{"study_id": 110285, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether CNR2 gene expression (linked to CB2R activation and reduced arachidonic acid production) is increased in aspirin-exacerbated respiratory disease (AERD).", "results_summary": "The study found upregulated CNR2 expression in AERD patients compared to controls, suggesting a potential role of the endocannabinoid system in modulating arachidonic acid-related inflammation in AERD. No significant differences in CNR1 (CB1R) expression were detected.", "population_specificity": "Patients with AERD, allergic fungal rhinosinusitis (AFRS), and controls undergoing endoscopic sinus or skull base procedures.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:54.438726+00:00"}
{"study_id": 110287, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess whether the cardioprotective effects of Aspirin are maintained when used alongside certain NANSAIDs, including potential interactions involving arachidonic acid metabolism.", "results_summary": "The study found that Aspirin maintains its cardioprotective effects when combined with naproxen, ibuprofen, meloxicam, and rofecoxib, despite some interactions at the platelet aggregation level. The reduced platelet aggregation caused by NANSAIDs may still be sufficient for cardioprotection, possibly due to Aspirin's involvement in other mechanisms like arachidonic acid metabolism.", "population_specificity": "Not specified (analysis based on aggregated studies including molecular interaction studies, randomized clinical trials, and epidemiological observations).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Interactions noted with naproxen, ibuprofen, celecoxib, meloxicam, diclofenac, and rofecoxib.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:55.723390+00:00"}
{"study_id": 110288, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify pharmacophores that serve as dual inhibitors of COX-2/5-LOX enzymes to develop safer anti-inflammatory agents.", "results_summary": "The abstract highlights the adverse effects of traditional NSAIDs and selective COX-2 inhibitors, emphasizing the need for dual inhibitors to mitigate side effects. It suggests that structural features balancing safety and efficacy could lead to novel anti-inflammatory agents.", "population_specificity": "Not specified (general human pathology context)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:58.761259+00:00"}
{"study_id": 110289, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine how MAG-DHA supplementation influenced erythrocyte fatty acid profiles, particularly the AA/DHA ratio, and inflammatory markers in CF patients.", "results_summary": "MAG-DHA supplementation increased DHA levels and decreased the AA/DHA ratio in erythrocytes, while also reducing pHLE complexes and IL-6 expression levels, suggesting potential anti-inflammatory effects.", "population_specificity": "Fifteen outpatients with Cystic Fibrosis, ages 18\u201348.", "effective_dosage": "8 \u00d7 625 mg MAG-DHA softgels daily (total 5,000 mg/day).", "study_duration": "60 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:59.288269+00:00"}
{"study_id": 110292, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the association between platelet count, platelet turnover, and platelet aggregation in patients with Essential Thrombocytosis (ET), using arachidonic acid as one of the agonists.", "results_summary": "The study found a positive correlation between platelet count and impedance aggregation when using arachidonic acid as an agonist (r = 0.48, P = 0.02), indicating increased aggregation potential in ET patients compared to healthy individuals.", "population_specificity": "24 ET patients who discontinued antiplatelet therapy prior to blood sampling.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:59.814373+00:00"}
{"study_id": 110290, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to determine if there were sex differences in post-AMI omega-3 fatty acids, including arachidonic acid (AA), and their associations with 12-month health status outcomes in young adults.", "results_summary": "The study found no significant sex differences in AA levels post-AMI and no significant associations between AA and 12-month health status outcomes after adjusting for demographic and clinical factors.", "population_specificity": "Young adults (aged 18-55 years) with acute myocardial infarction (AMI) in the US.", "effective_dosage": "Not specified", "study_duration": "Biomarkers measured 1 month post-AMI, with follow-up at 12 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:00.120911+00:00"}
{"study_id": 110291, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of PUFA metabolites, particularly those derived from Arachidonic Acid via the CYP/sEH pathway, in angiogenesis, vascular stability, and their potential implications in cancer development.", "results_summary": "The study highlights that PUFA metabolites, especially those generated by CYP enzymes and sEH, play significant roles in physiological and pathological angiogenesis, though their involvement in tumor angiogenesis and vascular integrity has been largely overlooked. These metabolites are recognized as important signaling mediators, with potential implications for anti-cancer therapies.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:00.796723+00:00"}
{"study_id": 110294, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review recent findings on leukotriene receptors derived from arachidonic acid to explore their potential as new drug targets.", "results_summary": "The study highlights that leukotrienes, derived from arachidonic acid, play key roles in allergic and inflammatory reactions and have potential as drug targets, with existing inhibitors and antagonists already in clinical use for conditions like asthma and allergic rhinitis. Recent research using cloned receptors and genetically engineered mice has revealed new pathophysiological roles for leukotrienes.", "population_specificity": "Not specified (focus on molecular and animal studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:02.970384+00:00"}
{"study_id": 110293, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the inflammatory response, including the role of arachidonic acid metabolites, between open repair (OR) and endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA).", "results_summary": "The study found that EVAR, while generally causing less systemic inflammatory response (SIR) than OR, may still trigger inflammation due to the release of arachidonic acid metabolites during intra-luminal thrombus manipulation, leading to post-implantation syndrome. Polyester endografts were positively correlated with this syndrome.", "population_specificity": "Patients undergoing repair for abdominal aortic aneurysm (AAA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:03.224866+00:00"}
{"study_id": 110295, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of arachidonic acid metabolism in inflammation and the efficacy of COX-2 selective inhibitors as anti-inflammatory agents with reduced gastrointestinal side effects compared to traditional NSAIDs.", "results_summary": "The study highlights that COX-2 selective inhibitors, which target arachidonic acid metabolism, show equivalent efficacy to conventional NSAIDs but with fewer gastrointestinal side effects, making them promising for treating chronic inflammatory conditions.", "population_specificity": "Not specified (general review of inflammatory pathologies including autoimmune diseases, metabolic syndrome, neurodegenerative diseases, and cardiovascular pathologies).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:03.601534+00:00"}
{"study_id": 110297, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether placental lipid droplet composition, including arachidonic acid, is modifiable by a diet and physical activity intervention in obese pregnant women.", "results_summary": "PCs carrying arachidonic acid were inversely associated with placental weight, suggesting a potential role in placental lipid metabolism. The intervention modestly altered LD FA composition, including effects on arachidonic acid-related species.", "population_specificity": "Obese pregnant women (intervention group n=20, control group n=23).", "effective_dosage": "Not specified", "study_duration": "Duration of pregnancy (exact length not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:07.227189+00:00"}
{"study_id": 110296, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the distribution and regulation of arachidonic acid (AA)-containing lipids, particularly ethanolamine plasmalogens (PlsEtn), in healthy, adenomatous, and carcinomatous colon mucosa to understand their role in cell differentiation and pathophysiological states.", "results_summary": "The study found that AA-containing PlsEtn species were more abundant at the base of colon crypts (where stem cells reside) and decreased toward the crypt apex, while mono-/diunsaturated species showed the opposite trend. These gradients were disrupted in polyps and carcinoma, linking AA-containing lipid regulation to cell differentiation and disease states.", "population_specificity": "Human colon mucosa samples (healthy, adenomatous, and carcinomatous)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:08.154797+00:00"}
{"study_id": 110299, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid in platelet activation and its inhibition by aspirin, as well as its relevance in assessing platelet reactivity in vascular diseases.", "results_summary": "The study found that arachidonic acid induces platelet activation, leading to P-selectin expression, which is blocked by aspirin. High platelet reactivity, measured via P-selectin expression, was associated with increased recurrence risk after myocardial infarction.", "population_specificity": "Patients with vascular diseases (e.g., myocardial infarction, ischemic stroke) and potential relevance to surgical/veterinary practice and mild bleeding disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Inhibited by aspirin (antiplatelet effect)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:09.405482+00:00"}
{"study_id": 110301, "supplement_id": 885, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, pharmacokinetics, and preliminary efficacy of RT001 (a deuterated ethyl linoleate that metabolizes into arachidonic acid) in Friedreich's ataxia patients.", "results_summary": "RT001 was safe and tolerable, with plasma levels nearing saturation by 28 days. It showed improvement in peak workload and trends in oxygen consumption and stride speed, though some results were not statistically significant.", "population_specificity": "Friedreich's ataxia patients (18 completed the study).", "effective_dosage": "1.8 or 9.0 g/day of RT001.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:09.973064+00:00"}
{"study_id": 110298, "supplement_id": 885, "safety_score": "30", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to understand the effects of celecoxib (a COX-2 inhibitor) on arachidonic acid metabolism and its association with blood pressure changes.", "results_summary": "Celecoxib increased CYP450- and LOX-derived oxylipins, particularly 5-HETE, 8-HETE, and 20-HETE, which were positively associated with elevated systolic blood pressure, especially in men and non-aspirin users. LOX-derived metabolites from arachidonic acid were strongly linked to blood pressure changes independent of celecoxib or aspirin use.", "population_specificity": "Participants from the Sel/Cel trial (n = 185; 90 celecoxib, 95 placebo) for colorectal adenomatous polyp prevention.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "Celecoxib and low-dose aspirin.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:11.668092+00:00"}
{"study_id": 110302, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers were examining the role of arachidonic acid (AA) in inflammation and lipid metabolism, particularly its conversion to prostaglandin E in the context of obesity-related chronic inflammation.", "results_summary": "The abstract suggests that arachidonic acid is involved in inflammatory signaling pathways, specifically through its conversion to prostaglandin E, which may contribute to altered lipid metabolism and carcinogenesis. No direct efficacy or safety outcomes related to AA supplementation were reported.", "population_specificity": "Not specified (abstract focuses on mechanistic pathways in obesity-related inflammation).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:11.905822+00:00"}
{"study_id": 112470, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review clinical practice guidelines for managing pregnancy following metabolic-bariatric surgery.", "results_summary": "The study identified consistent recommendations for managing pregnancy post-bariatric surgery, including contraception timing, nutritional care, and modified gestational diabetes screening, but noted inconsistencies in surgery-to-conception intervals and supplement dosing.", "population_specificity": "Women of reproductive age who underwent metabolic-bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:18.798358+00:00"}
